Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017766	p-c4	g/l (g/l)	7342	12026	0.28%
3017766	s-c4	g/l (g/l)	5461	8476	0.00%
3017766	p-c4	— (—)	702	914	100.00%	Distribution not available
3017766	s-c4	— (—)	407	531	100.00%	Distribution not available
3017766	s-c4h	g/l (g/l)	7	7	0.00%	Distribution not available
3017766	s-komplementtic4	g/l (g/l)	7	7	0.00%	Distribution not available	Distribution not available
3017766	p-c4d	mg/l (g/l)	6	6	0.00%
3017766	p-c4d	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1956

6839

2.65

322.83

1.8

1.6

0.23

0.24

g/l

0.99

1851

6467

Care involving dialysis

469

673

7.96

317.67

2.0

1.5

0.26

0.24

g/l

3.25

447

630

Other joint disorders

2487

5411

2.48

317.34

1.8

1.7

0.23

g/l

0.99

2363

5132

Pneumonias (Asthma/COPD co-morbidities)

2952

9103

2.23

317.02

1.9

1.7

0.24

0.23

g/l

1.58

2800

8642

Infections, IBD-co-morbidities

504

461

8.20

315.18

1.9

1.2

0.23

0.24

g/l

0.66

475

426

Pneumonia, organism unspecified

2666

8285

2.32

314.92

1.8

1.6

0.24

0.23

g/l

1.22

2535

7863

All pneumoniae

2963

9136

2.22

314.40

1.9

1.7

0.24

0.23

g/l

1.52

2811

8672

Unspecified kidney failure

461

656

7.73

311.89

1.5

1.4

0.26

0.23

g/l

5.66

440

619

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

454

641

8.06

311.73

1.9

1.4

0.25

0.24

g/l

1.14

429

614

Coagulation defects, purpura and other haemorrhagic conditions

860

2149

4.32

310.86

2.5

1.7

0.22

0.23

g/l

6.79

806

2033

Neurological diseases, wide definition

834

802

5.38

307.78

1.9

1.3

0.23

g/l

0.12

795

751

Diseases of arteries, arterioles and capillaries

1950

5382

2.77

307.65

1.7

1.6

0.23

0.24

g/l

3.86

1864

5075

Interstitial lung disease endpoints

692

1287

5.90

307.65

1.8

1.4

0.23

0.24

g/l

2.62

667

1216

Cardiovascular diseases

1958

3657

2.97

307.65

2.0

1.7

0.23

0.22

g/l

4.99

1880

3471

Heart failure, not strict

2348

5515

3.01

307.65

1.9

1.6

0.25

0.23

g/l

6.50

2234

5224

Pain in limb

2416

6738

2.47

307.65

1.8

1.7

0.24

0.23

g/l

3.48

2300

6388

All kidney diseases

3508

8452

2.95

307.65

2.0

1.6

0.25

0.23

g/l

25.70

3351

7997

Reimbursement for rheumatic diseases

3243

6345

5.56

307.65

2.8

1.3

0.21

0.24

g/l

48.43

3114

5992

Used for control exclusion in common control thyroid runs

3421

5401

3.31

307.65

2.1

1.2

0.22

0.24

g/l

17.50

3262

5117

Asthma, unspecified (mode)

1553

3930

3.07

307.65

1.6

0.24

0.23

g/l

2.68

1483

3728

ILD medications

5119

5740

5.11

307.65

2.2

1.3

0.23

0.24

g/l

6.46

4879

5427

Inflammatory bowel disease treatment related agents

5056

6610

4.51

307.65

2.1

1.4

0.23

0.24

g/l

7.56

4805

6264

ILD medications: azathioprine

794

1030

8.54

307.65

4.0

1.3

0.20

0.24

g/l

13.76

767

979

Other bacterial diseases

3097

8253

2.45

307.65

1.8

1.6

0.24

0.23

g/l

8.02

2935

7845

Systemic lupus erythematosus, unspecified

737

286

71.52

307.65

6.7

1.3

0.18

0.24

g/l

22.77

708

273

SLE, strict definition

809

328

62.06

307.65

6.7

1.3

0.18

0.24

g/l

25.27

779

312

ILD medications: prednisolone, methylprednisolone, prednisone

4956

5621

5.22

307.65

2.2

1.3

0.23

0.24

g/l

7.16

4717

5312

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

647

274

18.74

307.65

1.8

1.2

0.23

0.24

g/l

1.24

624

251

ILD medications: immunosuppressive drugs

3588

5135

7.07

307.65

2.6

1.3

0.22

0.24

g/l

14.81

3438

4851

Other specified/unspecified systemic involvement of connective tissue

894

443

32.15

307.65

3.4

1.2

0.20

0.25

g/l

21.33

869

417

Sicca syndrome [Sjögren]

1038

706

20.50

307.65

2.6

1.2

0.20

0.25

g/l

29.11

1006

671

Fever of other and unknown origin

2345

4970

4.44

307.65

2.1

1.6

0.24

0.23

g/l

2.82

2224

4717

Bacterial infection, other or unspecified

1893

5116

3.26

307.65

1.8

1.6

0.24

0.23

g/l

5.54

1775

4848

Asthma, excluding more controls

2294

3963

3.11

307.65

1.6

1.7

0.24

0.23

g/l

3.33

2192

3762

Other and unspecified dermatitis

1988

6125

3.42

307.65

1.9

1.7

0.23

g/l

3.74

1891

5814

Other disorders of skin and subcutaneous tissue

2341

7399

2.93

307.65

2.1

1.6

0.23

g/l

1.06

2207

7014

Cutaneous lupus erythematosus

382

209

30.83

307.65

4.0

1.5

0.20

0.23

g/l

6.47

368

198

Diseases of the skin and subcutaneous tissue

2859

5667

2.60

307.65

1.8

1.6

0.23

g/l

0.45

2707

5393

Bacterial infection, other or unspecified

1774

4703

3.42

307.65

1.8

1.5

0.24

0.23

g/l

4.92

1663

4447

Urticaria and erythema

1602

4644

3.68

307.65

1.9

1.7

0.23

g/l

0.74

1505

4421

Vasculitis limited to skin, not elsewhere classified

344

216

23.76

307.65

1.8

1.5

0.24

0.23

g/l

0.28

331

208

Certain disorders involving the immune mechanism

913

2106

4.73

307.65

1.9

1.7

0.24

g/l

0.05

854

2003

Dialysis, with operation codes

701

1049

7.53

307.65

1.9

1.5

0.26

0.23

g/l

6.83

662

989

Other bacterial diseases

2931

7915

2.57

307.65

1.8

1.6

0.24

0.23

g/l

7.50

2770

7520

SLE (Finngen)

824

201

99.02

307.65

6.7

1.1

0.18

0.25

g/l

23.91

794

191

ILD, hospital admissions 1, main diag only

639

1138

6.20

307.65

1.8

1.4

0.23

0.24

g/l

2.30

618

1075

Influenza and pneumonia

3118

9095

2.24

307.65

1.9

1.7

0.23

g/l

1.22

2957

8636

Other specified/unspecified arthritis

1185

2509

5.07

307.65

1.8

1.6

0.23

0.24

g/l

1.14

1138

2371

Interstitial lung disease

692

1287

5.90

307.65

1.8

1.4

0.23

0.24

g/l

2.62

667

1216

Other arthritis (FG)

1335

2516

5.69

307.65

1.8

1.2

0.23

0.24

g/l

4.35

1280

2377

Other respiratory diseases principally affecting the interstitium

797

1544

5.62

307.65

1.8

1.5

0.23

0.24

g/l

2.05

767

1461

Other necrotizing vasculopathies (FG)

443

369

14.44

307.65

2.1

1.2

0.24

0.25

g/l

0.58

421

347

Systemic sclerosis (FG)

283

141

28.65

307.65

2.3

1.1

0.20

0.24

g/l

3.61

270

131

Bacterial Sepsis

1585

3889

3.65

307.65

1.9

1.5

0.24

0.23

g/l

1.60

1479

3673

Rheumatoid arthritis, including avohilmo

1385

4369

3.34

307.65

2.0

1.6

0.22

0.24

g/l

13.03

1316

4104

Nephropathy related operations

656

1135

6.49

307.65

1.9

1.4

0.26

0.24

g/l

4.71

619

1072

Implicit bacterial Sepsis

1499

3698

3.67

307.65

1.8

1.5

0.24

0.23

g/l

2.34

1399

3493

Other and unspecified effects of external causes

1214

3453

3.75

307.65

1.7

1.8

0.23

g/l

0.95

1110

3305

Systemic sclerosis

283

186

21.61

307.65

2.3

1.1

0.20

0.25

g/l

6.22

270

176

Other and unspecified vasculitis limited to skin

327

193

26.01

307.65

1.8

1.5

0.24

0.23

g/l

0.30

314

185

ILD, hospital admission 2, with pulmonary infections

478

678

7.82

307.65

1.9

1.4

0.23

0.24

g/l

0.56

458

638

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2728

6673

2.55

307.65

1.9

1.6

0.24

0.23

g/l

2.43

2592

6332

Other systemic involvement of connective tissue

2447

2460

11.97

307.65

2.6

1.2

0.21

0.24

g/l

50.97

2358

2301

Implicit bacterial Sepsis

1392

3413

3.80

307.65

1.8

1.5

0.24

0.23

g/l

2.06

1295

3219

Autoimmune diseases

3776

5842

3.41

307.65

2.1

1.2

0.22

0.24

g/l

20.24

3601

5532

Acute renal failure

1000

1706

6.40

307.65

1.9

1.5

0.26

0.23

g/l

10.18

949

1605

Other necrotizing vasculopathies

531

508

12.62

307.65

2.6

1.2

0.24

0.25

g/l

0.73

506

479

Glomerulonephritis

623

910

7.87

307.65

2.7

1.5

0.25

0.24

g/l

3.05

592

858

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3755

8237

3.29

307.65

2.0

1.6

0.23

g/l

1.51

3548

7825

Asthma (mode)

2298

4282

2.96

307.65

1.6

1.7

0.24

0.23

g/l

3.04

2190

4069

First line medication for Crohn's disease

4623

5878

4.46

307.65

2.2

1.3

0.23

0.24

g/l

4.74

4395

5576

Implicit Sepsis

2472

7240

2.57

307.65

1.8

1.6

0.24

0.23

g/l

3.95

2332

6883

Other systemic involvement of connective tissue (FG)

2402

1919

14.92

307.65

2.6

1.2

0.21

0.24

g/l

45.30

2314

1804

2728

6673

2.55

307.65

1.9

1.6

0.24

0.23

g/l

2.43

2592

6332

Chronic kidney disease

1585

2344

7.30

307.65

1.8

1.5

0.26

0.23

g/l

22.32

1516

2194

Oral corticosteroids

4944

6355

4.90

307.65

2.2

1.4

0.23

0.24

g/l

7.58

4688

6019

Second line medication for Crohn's disease

2871

6912

4.47

307.65

2.6

1.5

0.22

0.24

g/l

20.85

2755

6540

Other peripheral vascular diseases

626

736

10.16

307.65

1.8

1.7

0.21

0.23

g/l

8.79

608

692

Other interstitial pulmonary diseases

692

1276

5.95

307.65

1.8

1.4

0.23

0.24

g/l

2.64

667

1205

Autoimmune diseases related-to ILD

3911

8144

4.36

307.65

2.7

1.3

0.22

0.24

g/l

36.09

3743

7685

Glomerular diseases

1234

1748

8.15

307.65

2.9

1.5

0.25

0.24

g/l

5.49

1173

1650

Polyarthropathies

2741

4690

4.01

307.65

1.8

1.6

0.23

g/l

0.92

2615

4439

Anaemias

1002

1153

6.03

307.65

2.3

1.9

0.23

0.22

g/l

4.92

956

1102

Renal failure

2135

3546

5.76

307.65

1.8

1.5

0.26

0.23

g/l

27.40

2039

3318

Seropositive rheumatoid arthritis

861

1836

4.94

307.65

2.0

1.2

0.21

0.24

g/l

19.66

820

1727

Finngen Rheumatological endpoints

3829

5520

4.13

307.65

2.4

1.2

0.22

0.24

g/l

25.45

3658

5217

SLE, ICD10

809

328

62.06

307.65

6.7

1.3

0.18

0.24

g/l

25.27

779

312

General symptoms and signs

3472

6118

2.93

307.65

1.9

1.6

0.23

g/l

1.63

3301

5814

Other specific joint derangements/joint disorders

2657

5306

3.37

307.65

1.8

1.7

0.23

g/l

1.15

2519

5034

Asthma

2340

4230

2.99

307.65

1.6

1.7

0.24

0.23

g/l

3.11

2235

4018

Arthropathies

2649

5434

2.53

307.65

1.8

1.7

0.23

g/l

0.61

2534

5155

Raynaud syndrome

703

923

9.20

307.65

1.8

0.21

0.23

g/l

10.82

681

865

Asthma (only as main-diagnosis), excluding more controls

2165

3963

3.23

307.65

1.6

1.7

0.24

0.23

g/l

2.78

2061

3762

Asthma, unspecified (mode), excluding more controls

1529

3684

3.21

307.65

1.6

0.24

0.23

g/l

2.94

1463

3492

L04AX Other immunosuppressants

2819

6703

4.53

307.65

2.6

1.5

0.22

0.24

g/l

20.68

2705

6340

Dermatitis and eczema

3445

9133

2.41

307.65

1.8

1.7

0.23

g/l

2.70

3269

8662

Systemic connective tissue disorders

3489

3185

13.45

307.65

3.0

1.2

0.21

0.24

g/l

61.50

3355

2984

Autoimmune diseases excluding thyroid diseases

4425

5797

4.38

307.65

2.3

1.2

0.22

0.24

g/l

31.98

4218

5490

All chronic kidney diseases

2528

4354

5.09

307.65

2.1

1.6

0.25

0.23

g/l

27.45

2420

4104

Dyspnoea

2714

8682

2.38

307.65

1.8

1.7

0.24

0.23

g/l

1.92

2589

8217

Implicit Sepsis

2345

6582

2.78

307.65

1.8

1.6

0.24

0.23

g/l

2.72

2209

6255

Abnormalities of breathing

2795

6459

2.59

307.65

1.8

1.7

0.24

0.23

g/l

3.21

2668

6138

Mixed connective tissue disease

1023

625

26.70

307.65

3.5

1.5

0.19

0.24

g/l

21.64

994

589

Asthma (only as main-diagnosis)

2196

4230

3.10

307.65

1.6

1.7

0.24

0.23

g/l

2.44

2091

4018

Adverse effects, not elsewhere classified

1063

2386

4.89

307.65

1.7

1.8

0.24

0.23

g/l

1.40

966

2272

Autoimmune diseases excluding thyroid diseases, strict definition

4288

5613

4.40

307.65

2.3

1.2

0.22

0.24

g/l

29.76

4091

5319

L04AA Selective immunosuppressants

1214

2597

5.16

307.65

3.5

1.5

0.22

0.24

g/l

8.42

1172

2453

Condition for Implicit Sepsis (Organ dysfunction codes)

2496

7444

2.44

307.65

1.8

1.6

0.24

0.23

g/l

3.42

2357

7072

Other soft tissue disorders, not elsewhere classified

2997

6932

2.61

307.65

1.8

1.7

0.24

0.23

g/l

2.26

2855

6576

Azathioprine

794

1173

7.49

307.65

4.0

1.4

0.20

0.24

g/l

12.81

767

1118

Urticaria

1332

3767

3.78

307.65

1.8

0.23

g/l

0.38

1246

3591

Dermatitis

2215

7381

3.13

307.65

1.8

1.7

0.23

g/l

3.44

2104

6996

Rheumatoid arthritis

1216

2660

4.33

307.65

2.0

1.5

0.22

0.24

g/l

10.75

1156

2508

Systemic lupus erythematosus

824

285

69.40

307.65

6.7

1.1

0.18

0.25

g/l

25.05

794

268

Headache

1989

5749

2.85

307.65

1.8

1.6

0.23

g/l

0.65

1882

5463

Oedema, not elsewhere classified

1265

2766

4.80

307.65

1.7

1.6

0.24

0.23

g/l

2.53

1181

2612

Pain in joint

2248

3883

3.86

307.65

1.8

1.6

0.23

g/l

0.60

2132

3691

ILD, hospital admissions

689

1274

5.94

307.65

1.8

1.4

0.23

0.24

g/l

2.54

664

1204

Renal tubulo-interstitial diseases

3044

8030

2.94

307.65

1.9

1.7

0.25

0.23

g/l

24.36

2903

7604

Glomerular disorders in diseases classified elsewhere

812

989

9.63

307.65

3.3

1.4

0.25

0.24

g/l

2.95

769

933

Other and unspecified urticaria

893

2320

4.15

305.91

1.8

0.23

g/l

1.46

830

2205

Septicaemia

1257

3746

3.27

305.55

1.9

1.5

0.24

0.23

g/l

3.44

1185

3542

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2870

9073

2.21

302.54

1.9

1.7

0.24

0.23

g/l

1.39

2719

8616

Tramadol

2312

5942

2.46

300.40

1.8

1.7

0.24

0.23

g/l

6.27

2195

5631

Cardiovascular diseases (excluding rheumatic etc)

1999

4438

2.67

300.16

2.1

1.7

0.24

0.22

g/l

12.82

1915

4218

Examination and observation for other reasons

1753

3651

2.86

299.96

1.8

1.5

0.23

0.24

g/l

3.07

1667

3486

Systemic sclerosis, icd10

283

239

16.83

295.26

2.3

1.6

0.20

0.24

g/l

4.77

270

229

Implicit viral Sepsis

996

2845

3.68

294.27

2.1

1.6

0.23

g/l

0.29

929

2691

Asthma-related infections

1842

7229

2.58

294.00

1.7

0.24

0.23

g/l

3.06

1753

6842

Asthma, hospital admission 2, infections

1842

7229

2.58

294.00

1.7

0.24

0.23

g/l

3.06

1753

6842

Diseases of the musculoskeletal system and connective tissue

1428

2234

3.29

292.66

2.0

1.2

0.23

0.24

g/l

5.30

1364

2122

Explicit Sepsis

1334

4220

3.07

291.76

1.9

1.5

0.24

0.23

g/l

2.53

1261

3993

Condition for Implicit Sepsis (Organ dysfunction codes)

2549

7888

2.29

291.15

1.8

1.6

0.24

0.23

g/l

3.94

2416

7502

Hypertensive diseases (excluding secondary)

1606

3263

2.96

290.17

2.1

1.6

0.25

0.22

g/l

14.69

1538

3087

Malaise and fatigue

1416

3960

2.97

284.29

1.7

1.5

0.24

0.23

g/l

0.70

1333

3745

Abnormal findings on diagnostic imaging of lung

1407

4809

2.91

282.30

1.7

1.5

0.23

0.24

g/l

1.12

1326

4537

Immunodeficiencies

371

473

9.52

281.74

2.1

1.6

0.22

0.24

g/l

1.86

333

446

Aplastic and other anaemias

1359

4429

2.97

280.94

1.8

1.5

0.24

g/l

0.19

1276

4173

Other septicaemia

1115

3362

3.32

280.37

1.8

1.5

0.24

0.23

g/l

2.91

1057

3176

Any reimbursement code in KELA

1653

2945

2.89

274.92

2.1

1.4

0.23

g/l

0.27

1572

2796

Certain infectious and parasitic diseases

2669

6049

2.26

273.42

1.9

1.6

0.23

g/l

0.62

2532

5764

Other heart diseases

1454

3329

2.95

271.27

2.0

1.7

0.24

0.22

g/l

8.09

1386

3162

Heart failure and antihypertensive medication

770

1164

4.53

263.58

1.8

1.6

0.24

0.23

g/l

3.33

736

1102

Other pulmonary diagnosis

2080

4282

2.49

263.00

1.8

1.7

0.24

0.23

g/l

2.07

1982

4069

Viral Sepsis

735

1849

4.22

261.70

2.2

1.5

0.24

0.23

g/l

0.64

680

1751

Other and unspecified anaemias

1242

4109

2.99

261.50

1.8

1.5

0.24

0.23

g/l

0.16

1170

3875

Implicit viral Sepsis

733

1846

4.21

260.59

2.2

1.5

0.24

0.23

g/l

0.65

679

1748

Other anaemias

1248

4147

2.97

259.30

1.8

1.5

0.24

0.23

g/l

0.13

1176

3911

Other diseases of pleura

1280

3946

2.95

257.96

1.9

1.5

0.24

g/l

0.46

1214

3710

1443

5448

2.73

257.45

1.7

1.8

0.24

0.23

g/l

2.79

1376

5154

GASTRO-related operations

2158

4581

2.41

256.53

1.8

1.6

0.23

g/l

1.67

2044

4397

Any gastric operation

2158

4581

2.41

256.53

1.8

1.6

0.23

g/l

1.67

2044

4397

Excluding asthma or asthma-COPD overlap

2061

4282

2.47

255.69

1.8

1.7

0.24

0.23

g/l

1.74

1963

4069

ILD differential diagnosis

2046

4282

2.45

249.97

1.8

1.7

0.24

0.23

g/l

1.52

1948

4069

COPD differential diagnosis

2046

4284

2.45

249.74

1.8

1.7

0.24

0.23

g/l

1.54

1948

4071

ILD, hospital admissions 3, with pneumonia sepsis

390

595

7.24

247.81

1.8

1.4

0.23

0.24

g/l

0.40

375

562

Abnormal findings on examination of blood, without diagnosis

1356

4640

2.78

247.81

1.8

1.6

0.24

g/l

0.13

1281

4390

Asthma (diagnoses ohter than nonallergic)

2484

9936

2.13

247.20

1.6

1.8

0.24

0.23

g/l

3.95

2363

9413

Fibromyalgia

485

925

5.80

245.73

1.9

1.8

0.23

g/l

0.98

456

867

Antihypertensive medication - note that there are other indications

1793

3794

2.57

245.48

2.1

1.7

0.23

0.22

g/l

8.65

1717

3603

Ulcer of lower limb, not elsewhere classified

541

1130

5.15

244.96

1.8

1.4

0.25

0.24

g/l

2.12

508

1069

Symptoms and signs involving the circulatory and respiratory systems

2703

6477

2.13

242.23

1.9

1.7

0.23

g/l

1.58

2581

6155

L04AD Calcineurin inhibitors

546

1171

5.16

241.87

2.7

1.6

0.24

0.23

g/l

0.25

515

1107

Heart failure,strict

1345

3440

2.85

241.87

1.7

1.5

0.24

g/l

0.68

1275

3247

Pain in throat and chest

2257

6203

2.23

237.29

1.8

1.6

0.23

g/l

0.68

2153

5890

Secondary hypertension

358

513

7.53

236.51

2.8

1.5

0.25

0.23

g/l

3.96

338

486

Nephrotic syndrome

265

276

12.06

236.47

2.3

1.3

0.26

0.24

g/l

1.97

254

262

Extracorporeal dialysis

357

530

7.77

235.07

2.0

1.4

0.26

0.24

g/l

1.91

337

507

COPD/asthma/ILD related infections

2732

6674

2.09

232.85

1.9

1.6

0.24

0.23

g/l

2.20

2602

6333

COPD/asthma related infections

2732

6674

2.09

232.85

1.9

1.6

0.24

0.23

g/l

2.20

2602

6333

Hypothyroidism, strict autoimmune

1716

4671

2.47

231.60

1.8

1.2

0.23

0.24

g/l

6.82

1615

4419

Other disorders of lacrimal gland

1158

4177

2.90

230.80

2.3

1.6

0.22

0.23

g/l

5.21

1109

3929

Opioids

2637

6640

2.11

230.79

1.8

1.7

0.24

0.23

g/l

6.11

2500

6301

Pain, not elsewhere classified

851

2589

3.42

227.15

1.8

1.7

0.24

0.23

g/l

1.04

819

2453

Purpura and other haemorrhagic conditions

578

1369

4.57

224.74

2.5

1.6

0.22

0.24

g/l

5.31

534

1292

Cerebrovascular diseases (FINNGEN)

897

1907

3.45

221.14

1.9

1.6

0.25

0.23

g/l

6.51

862

1805

Other heart diseases, wide

2539

7675

2.07

220.88

1.8

1.7

0.24

0.23

g/l

1.59

2423

7283

Codeine

2483

6547

2.10

219.57

1.8

1.7

0.24

0.23

g/l

6.13

2342

6213

Sulfasalazine

798

2402

3.45

216.46

1.5

1.4

0.22

0.24

g/l

5.43

748

2275

Asthma, hospital admissions , main diagnosis only

2295

10004

2.07

216.45

1.6

1.8

0.24

0.23

g/l

2.29

2183

9475

Gout

731

1790

3.74

216.04

1.4

0.26

0.24

g/l

8.74

694

1687

Asthma-related pneumonia

1075

3847

2.90

215.60

1.7

1.6

0.24

0.23

g/l

1.32

1026

3610

Asthma-related pneumonia or sepsis

1076

3858

2.89

215.00

1.7

1.6

0.24

0.23

g/l

1.30

1027

3620

Asthma, hospital admissions 3, pneumonia

1076

3858

2.89

215.00

1.7

1.6

0.24

0.23

g/l

1.30

1027

3620

Medical observation and evaluation for suspected diseases and conditions

1724

3662

2.46

214.82

1.9

1.5

0.23

0.24

g/l

1.76

1655

3496

Diseases of arteries, arterioles and capillaries (FINNGEN)

695

1233

4.07

213.27

1.6

1.5

0.24

0.23

g/l

1.75

658

1165

Enlarged lymph nodes

552

1309

4.46

212.46

2.6

1.7

0.22

0.23

g/l

1.81

529

1230

Polymyalgia rheumatica

452

914

5.29

212.33

1.6

1.2

0.24

0.25

g/l

1.13

429

852

Disorders of thyroid, IBD co-morbidities

452

560

5.87

212.30

1.8

1.2

0.23

g/l

0.72

425

521

Other disorders involving the immune mechanism, not elsewhere classified

255

292

10.83

211.74

2.0

1.5

0.26

0.24

g/l

1.60

239

277

Hypertension, essential

2043

5332

2.22

208.05

1.9

1.7

0.25

0.23

g/l

23.80

1945

5068

Chronic lower respiratory diseases

3173

9147

1.88

204.98

1.6

1.8

0.24

0.23

g/l

3.33

3015

8673

2946

8038

1.93

203.40

1.8

1.7

0.24

0.23

g/l

1.90

2797

7624

Hypertensive diseases

2092

5561

2.17

202.15

2.0

1.7

0.25

0.23

g/l

19.61

1996

5286

Soft tissue disorders

2663

7007

1.99

201.74

1.8

1.7

0.23

g/l

1.56

2536

6648

Disorders of lacrimal system

1290

5248

2.54

199.98

2.3

1.6

0.22

0.23

g/l

5.51

1236

4949

Hypertension

2085

5559

2.17

199.87

2.0

1.7

0.25

0.23

g/l

19.70

1989

5284

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

239

273

10.88

198.94

1.9

1.5

0.26

0.24

g/l

2.45

223

260

Erysipelas

1763

6162

2.23

196.51

1.7

1.6

0.24

0.23

g/l

4.07

1660

5845

Pleural effusion

519

1263

4.36

193.50

1.9

1.5

0.24

g/l

0.16

495

1198

Other diseases of pericardium

243

288

9.59

193.34

2.5

1.4

0.24

g/l

0.33

229

269

Parasetamol

1911

4417

2.23

192.70

1.8

1.7

0.24

0.23

g/l

5.53

1818

4189

Heart failure, strict

1418

4178

2.46

192.17

1.7

1.5

0.24

g/l

0.32

1346

3937

Bronchitis

2814

9553

1.89

191.90

1.9

1.7

0.24

0.23

g/l

1.36

2666

9065

Symptoms and signs involving the skin and subcutaneous tissue

1941

9343

2.09

189.28

1.9

1.7

0.23

g/l

3.07

1849

8848

Dorsalgia

2586

7197

1.96

189.09

1.7

0.23

g/l

0.21

2452

6843

Asthma, including avohilmo

3057

9469

1.85

188.76

1.6

1.8

0.24

0.23

g/l

2.56

2905

8977

Polyneuropathies and other disorders of the peripheral nervous system

705

2152

3.45

188.49

1.8

1.5

0.23

0.24

g/l

2.32

666

2034

Methotrexate

466

1066

4.62

187.95

2.3

1.3

0.21

0.24

g/l

9.27

448

1013

Immunodeficiency with predominantly antibody defects

230

273

10.65

186.44

2.1

1.7

0.22

0.24

g/l

0.79

213

258

All-cause Heart Failure

1384

4106

2.45

185.16

1.7

1.5

0.24

g/l

0.23

1318

3866

Seropositive rheumatoid arthritis, wide

860

2982

3.02

184.70

2.0

1.6

0.21

0.24

g/l

14.14

819

2807

Other and unspecified polyneuropathies, also in other diseases

631

1824

3.66

183.99

1.8

1.5

0.23

0.24

g/l

1.98

600

1724

Erysipelas

1349

5088

2.41

183.75

1.7

1.5

0.24

0.23

g/l

3.02

1262

4825

Diseases of oesophagus, stomach and duodenum

2738

8839

1.89

183.73

1.8

1.7

0.23

g/l

0.03

2574

8407

Polyarthrosis

600

1556

3.75

179.72

1.6

1.4

0.23

0.24

g/l

2.92

577

1464

Dental caries

790

2535

3.12

179.18

1.9

1.6

0.24

0.23

g/l

0.30

754

2398

Codeine or tramadol medication

2898

8747

1.85

177.77

1.8

1.7

0.24

0.23

g/l

5.20

2735

8300

Gout, FINNGEN

731

2346

3.22

177.68

1.4

0.26

0.24

g/l

8.81

694

2204

CR(E)ST syndrome

174

152

16.07

177.56

2.0

1.6

0.20

0.24

g/l

3.93

163

147

Other/unspecified seropositive rheumatoid arthritis

843

2959

2.98

177.06

2.0

1.6

0.21

0.24

g/l

13.64

803

2785

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

844

1313

3.29

174.52

1.8

1.5

0.23

g/l

0.97

798

1258

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

834

2935

2.98

174.41

2.0

1.6

0.21

0.24

g/l

12.73

794

2762

Low back pain

1965

7027

2.05

173.84

1.7

0.24

0.23

g/l

0.98

1853

6680

Migraine

1481

5484

2.25

169.20

1.9

1.8

0.22

0.23

g/l

0.53

1406

5213

Persons encountering health services for specific procedures and health care

2774

9271

1.83

168.21

1.8

1.7

0.24

0.23

g/l

2.89

2631

8799

Cough

1092

4200

2.53

167.90

1.8

1.6

0.23

g/l

0.13

1038

3975

Osteopathies and chondropathies

1503

6557

2.19

165.68

2.0

1.6

0.23

g/l

0.78

1435

6200

Caries of dentine

703

2260

3.16

162.88

1.9

1.5

0.24

0.23

g/l

0.37

670

2138

Acute upper respiratory infections

2624

8971

1.83

162.38

1.8

1.7

0.24

0.23

g/l

1.86

2494

8505

Hypothyroidism (congenital or acquired)

706

1191

3.45

162.23

2.0

1.9

0.23

0.22

g/l

3.87

665

1136

Chronic nephritic syndrome

233

326

8.26

162.06

3.1

1.4

0.24

g/l

0.06

223

310

Seronegative rheumatoid arthritis

364

775

4.97

160.55

1.8

1.2

0.22

0.25

g/l

5.12

344

727

Neurological diseases

2160

5597

1.97

158.49

1.7

0.23

g/l

1.74

2054

5317

Acute upper respiratory infections of multiple and unspecified sites

1981

7620

1.97

157.15

1.9

1.7

0.24

0.23

g/l

2.52

1879

7224

Certain infectious and parasitic diseases

1766

4247

2.12

156.66

1.8

1.6

0.23

g/l

0.45

1678

4045

Hypothyroidism and >3 levothyroxin purchases

694

1188

3.40

156.34

2.0

1.9

0.23

0.22

g/l

4.21

655

1133

Hypothyroidism, levothyroxine purchases

694

1188

3.40

156.34

2.0

1.9

0.23

0.22

g/l

4.21

655

1133

Other diseases of intestines

2695

8634

1.81

155.91

1.7

0.23

g/l

1.00

2563

8196

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1155

3015

2.48

155.29

2.1

1.7

0.23

0.22

g/l

2.49

1102

2846

Metabolic disorders

2348

7785

1.87

155.20

1.6

1.7

0.25

0.23

g/l

13.92

2218

7398

Myalgia

728

2535

2.99

154.73

1.8

1.7

0.23

g/l

0.06

692

2401

Hard cardiovascular diseases

2033

6295

1.97

153.45

1.7

1.6

0.24

0.23

g/l

3.39

1937

5960

Lower back pain or/and sciatica

2644

9818

1.79

153.00

1.7

0.24

0.23

g/l

2.09

2493

9323

Complications of surgical and medical care, not elsewhere classified

2485

9529

1.82

153.00

1.8

1.7

0.24

0.23

g/l

0.85

2342

9042

Episodal and paroxysmal disorders

2729

7840

1.80

152.42

1.7

0.24

0.23

g/l

3.20

2599

7445

Persons encountering health services in other circumstances, wide

2862

8498

1.76

149.12

1.8

1.7

0.23

g/l

0.55

2736

8033

Codes for special purposes

1433

6910

2.13

147.68

1.9

1.7

0.24

0.23

g/l

2.69

1370

6555

Obesity related asthma

968

3983

2.52

147.41

1.5

1.7

0.26

0.23

g/l

13.93

924

3754

Disorders of eyelid, lacrimal system and orbit

2151

8916

1.87

147.06

2.0

1.6

0.23

g/l

2.89

2048

8445

Pain (limb, back, neck, head abdominally)

1663

4005

2.12

147.00

1.7

1.6

0.23

g/l

0.55

1577

3806

Other abnormal immunological findings in serum

179

209

10.80

146.96

1.9

1.5

0.21

0.24

g/l

2.75

169

198

General examination and investigation of persons without complaint and reported diagnosis

1509

3661

2.19

146.88

1.8

1.5

0.23

0.24

g/l

4.88

1444

3495

Provisional assignment of new diseases of uncertain etiology

1428

6902

2.12

146.25

1.9

1.7

0.24

0.23

g/l

2.66

1366

6546

Other dorsopathies, not elsewhere classified

2479

7234

1.82

145.24

1.7

0.23

g/l

0.04

2342

6878

Viral infections characterized by skin and mucous membrane lesions

2193

10405

1.84

145.12

2.1

1.6

0.22

0.23

g/l

9.10

2081

9871

Other (seronegative) rheumatoid arthritis, wide

616

2032

3.19

144.92

1.9

1.6

0.22

0.24

g/l

6.60

580

1906

Complications of medical and surgical care

1870

9129

1.92

144.48

1.8

1.7

0.24

0.23

g/l

2.30

1750

8670

Other special examinations and investigations of persons without complaint or reported diagnosis

1536

3662

2.16

143.56

1.9

1.5

0.23

0.24

g/l

1.99

1456

3496

Cardiac arrhythmias

1562

4948

2.10

143.37

1.8

1.7

0.24

0.22

g/l

6.00

1487

4685

Giant cell arteritis

199

267

8.40

142.82

1.7

1.2

0.26

0.24

g/l

0.72

186

248

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2708

8496

1.76

142.62

1.8

1.7

0.23

g/l

0.46

2583

8031

IgA nephropathy (IgA glomerulonephritis)

181

222

9.96

142.20

1.6

1.5

0.27

0.24

g/l

3.23

168

212

Intestinal infectious diseases

2363

10171

1.79

142.07

1.8

1.7

0.23

g/l

0.35

2221

9665

Diarrhoea and gastroenteritis of presumed infectious origin

1817

8676

1.92

140.40

1.8

1.7

0.23

g/l

0.62

1716

8243

Symptoms and signs involving the nervous and musculoskeletal systems

1505

7536

2.05

140.31

1.8

1.7

0.23

g/l

0.62

1435

7133

Covid-19 confirmed case

989

4201

2.43

140.16

1.9

1.6

0.24

0.23

g/l

2.38

943

3965

Nutritional anaemias

1247

5640

2.19

137.66

1.8

1.6

0.23

g/l

0.17

1188

5320

Other immunodeficiencies

134

117

16.49

137.25

2.6

1.5

0.20

0.23

g/l

2.57

116

117

Undetermined asthma, excluding more controls

380

944

4.21

137.16

1.6

1.5

0.24

0.23

g/l

0.55

367

891

Acute tubulo-interstitial nephritis

1485

6390

2.05

136.08

1.8

1.7

0.24

0.23

g/l

5.11

1402

6042

Atrial fibrillation and flutter

724

1639

2.94

135.84

1.7

1.6

0.24

0.23

g/l

3.20

690

1550

Haemorrhage from respiratory passages

805

2807

2.66

135.81

1.8

1.5

0.24

g/l

0.08

753

2646

Nerve, nerve root and plexus disorders

2569

9150

1.75

135.68

1.6

1.7

0.24

0.23

g/l

1.28

2435

8670

Isolated proteinuria

198

284

8.30

135.65

3.0

1.4

0.24

g/l

0.17

193

271

Other and unspecified iron deficiency

914

3803

2.48

135.50

1.8

1.6

0.23

g/l

0.19

874

3590

Diseases of the respiratory system

1483

3528

2.14

135.46

1.8

1.7

0.23

g/l

1.04

1400

3356

Vocal cord dysfunction

340

684

4.62

135.09

1.7

1.2

0.23

0.24

g/l

1.43

314

648

Other acute lower respiratory infections

1346

6276

2.09

132.58

1.8

1.7

0.24

0.23

g/l

0.96

1277

5944

Pericarditis

181

238

8.53

132.03

2.9

1.4

0.22

0.24

g/l

1.45

170

225

STROKE

1301

4169

2.17

131.73

1.8

1.6

0.24

0.23

g/l

1.75

1233

3941

Iron deficiency anaemia

1094

4899

2.26

131.58

1.8

1.6

0.23

g/l

0.03

1046

4622

Diabetic nephropathy, excluding more controls

471

1120

3.66

130.55

1.6

0.27

0.25

g/l

5.24

448

1072

Rheumatism, unspecified

458

1348

3.59

130.03

1.9

1.6

0.24

0.23

g/l

0.75

437

1270

Allergic asthma (mode), excluding more controls

620

2124

2.94

129.21

1.5

1.8

0.24

0.23

g/l

2.32

582

2025

Acute sinusitis

1372

6308

2.06

129.18

1.9

1.7

0.23

g/l

0.94

1303

5984

Gout, idiopatic and unspecified

626

2215

2.93

129.17

1.4

1.5

0.26

0.23

g/l

9.80

598

2097

Idiopathic pulmonary fibrosis

265

522

5.46

128.74

1.7

1.4

0.22

0.24

g/l

2.03

255

493

Undetermined asthma

380

989

4.02

128.66

1.6

1.5

0.24

0.23

g/l

0.57

367

935

Spondylopathies

1844

5874

1.91

128.64

1.6

1.7

0.24

g/l

0.03

1744

5566

Transplanted organ and tissue status

369

948

4.18

128.59

1.8

1.5

0.25

0.24

g/l

2.50

348

896

Diseases of salivary glands

923

3965

2.41

127.91

2.2

1.7

0.22

0.23

g/l

6.48

879

3756

Bacterial pneumoniae

973

3719

2.37

127.78

1.9

1.5

0.24

0.23

g/l

0.35

904

3519

Hypertensive heart and/or renal disease

593

1462

3.12

127.73

1.6

1.5

0.25

0.23

g/l

6.05

562

1388

Infections of the skin and subcutaneous tissue

1494

7632

1.98

127.72

2.0

1.7

0.24

0.23

g/l

1.53

1418

7264

Asthma/COPD (KELA code 203)

2306

9131

1.76

127.72

1.6

1.8

0.24

0.23

g/l

2.76

2192

8657

Other diseases of blood and blood-forming organs, wide

667

2468

2.82

127.01

2.1

1.6

0.22

0.24

g/l

5.50

621

2338

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

222

380

6.50

126.55

2.0

1.6

0.22

0.23

g/l

0.67

212

358

Depression medications

720

1250

2.96

126.19

1.8

0.24

0.22

g/l

7.03

690

1194

Intestinal infectious diseases

2755

9475

1.69

126.11

1.8

1.7

0.23

g/l

0.14

2605

8997

Biological medication for rheuma

590

2059

3.01

125.76

1.6

1.8

0.23

g/l

1.42

556

1948

Diarrhoea and gastroenteritis of presumed infectious origin

2455

9542

1.72

125.28

1.8

1.7

0.23

g/l

0.03

2335

9057

Idiopathic urticaria

165

211

9.48

125.17

1.6

1.5

0.23

g/l

0.12

157

200

Viral infections characterized by skin and mucous membrane lesions

1111

5190

2.20

124.94

2.2

1.6

0.23

g/l

1.54

1051

4922

Dorsopathies

2465

7284

1.75

124.56

1.7

0.23

g/l

0.12

2331

6926

Other disorders of fluid, electrolyte and acid-base balance

772

2930

2.59

124.33

1.7

1.6

0.23

g/l

0.52

726

2763

Osteoporosis

686

2418

2.75

123.50

2.2

1.5

0.22

0.24

g/l

3.93

650

2250

Anxiety disorders, excluding more controls

2076

7637

1.80

122.58

1.8

1.7

0.23

g/l

0.12

1959

7264

Allergic asthma (mode)

620

2186

2.86

122.56

1.5

1.8

0.24

0.23

g/l

2.24

582

2088

Anxiety disorders

2251

9144

1.74

121.27

1.8

1.7

0.23

g/l

0.65

2125

8690

Other disorders of skin and subcutaneous tissue, not elsewhere classified

439

1314

3.51

121.21

1.9

1.6

0.23

0.24

g/l

0.65

412

1240

Neurotic, stress-related and somatoform disorders

2233

9102

1.75

120.66

1.8

1.7

0.23

g/l

0.62

2108

8652

Other headache syndromes

1118

5307

2.16

120.43

1.8

0.23

g/l

0.39

1062

5036

Defects in the complement system

106

21.79

120.11

2.4

1.4

0.19

0.24

g/l

3.66

Abnormal findings on examination of urine, without diagnosis

224

409

6.14

119.71

2.8

1.4

0.24

g/l

0.07

217

388

Pulmonary heart disease, diseases of pulmonary circulation

800

3317

2.49

119.61

1.8

1.6

0.25

0.23

g/l

3.38

754

3120

Complications of procedures, not elsewhere classified

1960

9213

1.79

119.42

1.8

1.7

0.24

0.23

g/l

0.48

1849

8741

Implicit fungal Sepsis

258

533

5.24

118.94

1.7

1.5

0.24

g/l

0.23

235

507

Bacterial pneumonia, not elsewhere classified

914

3504

2.36

118.92

1.9

1.5

0.24

0.23

g/l

0.55

849

3315

Temporal arteritis

171

238

8.08

118.89

1.7

1.1

0.25

0.24

g/l

0.21

159

220

Chronic ulcer of skin, not elsewhere classified

246

489

5.42

118.34

1.9

1.3

0.24

g/l

0.01

230

466

Other general symptoms and signs

222

400

5.98

117.68

1.7

0.22

g/l

0.31

209

378

Gastro-oesophageal reflux disease

1628

7593

1.89

117.67

1.8

1.6

0.23

g/l

2.21

1531

7214

Diseases of the eye and adnexa

1979

5487

1.84

117.49

1.9

1.7

0.23

g/l

0.82

1889

5220

Chronic sinusitis

1115

5342

2.14

117.28

1.7

0.23

g/l

0.18

1057

5078

Heart failure and coronary heart disease

925

2832

2.37

116.62

1.6

1.5

0.24

0.23

g/l

1.34

879

2657

Oxycodone

867

3376

2.38

116.37

1.7

1.5

0.24

0.23

g/l

3.08

815

3182

Other and unspecified coagulation defects

253

529

5.32

116.04

3.3

1.8

0.21

0.23

g/l

2.60

244

502

Ischemic heart diseases

1878

6270

1.83

115.28

1.7

1.6

0.24

0.23

g/l

2.65

1785

5945

Secondary right heart disease

193

316

6.80

115.09

1.8

1.5

0.24

0.23

g/l

0.13

185

302

Disturbances of skin sensation

814

3468

2.43

115.07

1.9

1.8

0.23

g/l

1.38

769

3305

Non-ischemic cardiomyopathy

720

2279

2.62

114.87

1.8

1.5

0.23

g/l

0.09

682

2137

Gout, unspecified

520

1777

3.05

114.50

1.4

0.26

0.23

g/l

9.33

494

1678

Migraine with aura

748

3077

2.52

114.17

1.9

0.22

0.23

g/l

1.30

710

2939

Bacterial pneumonia (organism specified)

1051

4486

2.17

113.75

1.9

1.6

0.24

0.23

g/l

0.30

977

4239

Atrial fibrillation and flutter with reimbursement

556

1170

3.11

113.75

1.6

1.5

0.24

0.23

g/l

3.00

529

1103

Venous thromboembolism

1257

6142

2.02

113.23

1.8

1.6

0.24

0.23

g/l

3.08

1188

5791

Non-allergic asthma (mode), excluding more controls

455

1429

3.25

113.14

1.8

1.5

0.23

g/l

0.14

432

1345

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

342

919

3.98

111.93

1.5

1.7

0.25

0.23

g/l

2.07

321

872

Other coagulation defects

305

759

4.34

111.43

3.1

1.8

0.21

0.23

g/l

3.01

295

714

Acute bronchitis

1013

4675

2.18

111.33

1.8

1.7

0.24

0.23

g/l

1.58

961

4424

Liquid cancers, helper endpoint

945

3746

2.26

111.18

1.7

1.6

0.23

0.24

g/l

0.86

882

3538

Hypothyroidism, drug reimbursement

396

772

3.75

110.68

1.9

1.7

0.23

0.22

g/l

0.87

373

740

Percutaneous Coronary Intervention

1761

5970

1.84

110.47

1.7

1.6

0.24

0.23

g/l

1.57

1675

5655

Asthma and allergy

386

1111

3.57

110.08

1.6

1.7

0.24

0.22

g/l

3.33

363

1062

Other pleural conditions

307

771

4.21

109.82

1.9

1.5

0.24

g/l

0.15

295

728

Gastrointestinal diseases

1431

3640

2.00

109.79

1.9

1.7

0.23

g/l

0.04

1352

3477

Syncope and collapse

913

3507

2.27

109.64

1.7

1.5

0.23

g/l

0.02

872

3315

Gout, strict definition

460

1505

3.19

109.42

1.4

0.27

0.23

g/l

10.06

435

1423

Coronary revascularization (ANGIO or CABG)

1759

5972

1.84

109.38

1.6

0.24

0.23

g/l

1.66

1673

5657

Chronic rhinitis, nasopharyngitis and pharyngitis

867

3888

2.30

108.37

1.8

0.24

0.23

g/l

0.62

814

3700

Exposure to unspecified factor

2375

10432

1.66

108.28

1.8

1.7

0.24

0.23

g/l

4.19

2246

9903

Heart failure and bmi 25plus

777

2157

2.50

108.20

1.6

1.4

0.25

g/l

0.06

736

2033

Diabetic nephropathy

474

1578

3.13

107.31

1.6

1.5

0.27

0.25

g/l

4.18

451

1499

Kidney transplant status

234

490

5.26

106.87

2.0

1.4

0.26

0.24

g/l

1.95

220

464

Other pulmonary heart/vessel disease

198

358

6.09

106.44

1.7

1.5

0.24

0.23

g/l

0.21

190

342

Symptoms and signs involving the digestive system and abdomen

2279

6790

1.70

105.91

1.8

1.7

0.24

0.23

g/l

0.70

2150

6467

Noninfective enteritis and colitis

1180

5991

2.01

105.65

1.7

0.23

g/l

0.37

1117

5693

Other symptoms and signs involving the nervous and musculoskeletal systems

1080

5324

2.08

105.61

1.8

1.7

0.23

g/l

0.80

1035

5045

Gonarthrosis [arthrosis of knee](FG)

1313

3865

2.00

105.33

1.6

1.2

0.24

0.25

g/l

0.58

1243

3645

Non-allergic asthma (mode)

455

1491

3.12

105.30

1.8

1.5

0.23

g/l

0.18

432

1406

Valvular heart disease excluding rheumatic fever

1011

3434

2.17

104.45

1.8

1.5

0.23

0.24

g/l

3.56

954

3228

Non-rheumatic valve diseases

1004

3404

2.17

104.01

1.8

1.5

0.23

0.24

g/l

3.94

948

3200

Preparatory care for dialysis

201

379

5.92

103.70

1.9

1.5

0.26

0.24

g/l

2.29

192

360

Sciatica+with lumbago

1220

5782

1.98

103.41

1.7

0.24

0.23

g/l

0.65

1150

5486

Asthma and allergy, excluding more controls

386

1159

3.42

103.04

1.6

1.7

0.24

0.22

g/l

2.77

363

1104

Other/unspecified dorsalgia

915

4258

2.18

101.54

1.7

0.24

0.23

g/l

0.52

867

4046

Emergency coronary revascularization (for ACS)

1848

6463

1.77

101.40

1.6

0.24

g/l

1.50

1760

6111

Allergic purpura

173

294

6.70

100.03

1.6

1.5

0.24

g/l

0.29

161

282

Other and unspecified drugs and medicaments

315

865

3.90

100.02

1.6

1.7

0.25

0.23

g/l

1.60

294

820

Other and unspecified immunodeficiencies with predominantly antibody defects

120

139

11.36

99.92

1.8

1.6

0.23

g/l

0.15

108

134

Spondylosis

1202

5045

1.98

99.73

1.6

0.24

g/l

0.49

1137

4775

Major coronary heart disease event

1827

6359

1.76

99.29

1.6

0.24

0.23

g/l

2.70

1733

6022

Zoster [herpes zoster]

1152

5838

1.99

99.16

2.2

1.6

0.22

0.24

g/l

8.41

1095

5509

Abdominal and pelvic pain

2242

6790

1.68

99.06

1.7

0.24

0.23

g/l

0.91

2114

6467

Endocrine, nutritional and metabolic diseases

1888

5501

1.76

98.96

1.8

0.24

0.22

g/l

19.53

1795

5224

Osteoporosis with pathological fracture (FG)

197

379

5.51

97.94

2.3

1.2

0.23

0.24

g/l

1.52

184

353

Depression

2273

9517

1.64

97.75

1.7

0.23

g/l

0.62

2153

9043

Bleeding

1814

7534

1.74

97.57

1.8

1.6

0.24

0.23

g/l

1.36

1707

7152

All influenza

617

2500

2.54

97.00

1.9

1.6

0.23

g/l

0.14

580

2366

DVT of lower extremities and pulmonary embolism

947

4567

2.11

96.96

1.8

1.6

0.25

0.23

g/l

3.99

889

4303

Other intervertebral disc disorders

1853

6506

1.74

96.63

1.6

1.7

0.23

g/l

0.03

1740

6172

Dermatographic urticaria

274

701

4.22

96.48

1.7

1.8

0.23

g/l

0.08

254

660

Symptoms and signs concerning food and fluid intake

291

769

3.95

96.46

2.0

1.5

0.23

g/l

0.58

277

719

Genitourinary diseases

1250

3178

2.00

96.26

1.7

1.5

0.24

0.23

g/l

3.20

1196

3007

Explicit bacterial Sepsis

305

836

3.83

96.26

2.3

1.5

0.24

0.23

g/l

0.28

286

795

Mood disorders, excluding more controls

2185

7983

1.66

95.05

1.8

1.7

0.24

0.23

g/l

0.69

2063

7584

Diseases of liver

846

3971

2.19

94.43

1.8

1.6

0.23

0.24

g/l

2.29

795

3770

Symptoms and signs involving cognition, perception, emotional state and behaviour

2241

9492

1.63

94.31

1.7

0.23

g/l

0.02

2105

9026

Mood [affective] disorders

2391

9759

1.61

94.22

1.8

1.7

0.23

g/l

0.72

2262

9273

Mood disorders

2395

9766

1.61

94.09

1.8

1.7

0.23

g/l

0.75

2266

9278

Giant cell arteritis with polymyalgia rheumatica

171

304

6.30

94.05

1.7

1.5

0.25

0.23

g/l

1.00

159

284

Disorders of skin appendages

1217

6499

1.91

93.85

2.0

1.7

0.23

g/l

0.83

1140

6195

Diseases of the digestive system

1043

5272

2.01

93.47

1.8

1.6

0.23

g/l

1.51

981

4993

Other disorders of urethra and urinary system

1655

6892

1.76

93.32

1.7

0.24

0.23

g/l

0.77

1550

6539

Thrombocytopenia, unspecified

250

612

4.38

93.16

2.8

1.5

0.20

0.24

g/l

7.76

227

585

Psoriatic and enteropathic arthropathies

297

819

3.78

92.70

1.7

1.2

0.24

g/l

0.37

286

773

Irritable bowel syndrome

745

3354

2.29

92.40

1.7

1.8

0.23

g/l

0.15

713

3171

Atopic dermatitis

1400

6371

1.83

92.11

1.8

1.7

0.23

g/l

1.26

1327

6064

Abnormalities of heart beat

806

3663

2.21

92.08

2.0

1.6

0.23

g/l

0.19

769

3465

Arthrosis

1414

4206

1.87

91.80

1.7

1.6

0.24

g/l

0.27

1345

3976

Care involving use of rehabilitation procedures

1485

7771

1.79

91.71

1.9

1.7

0.23

g/l

0.10

1390

7361

Disorders of conjunctiva

1984

9758

1.66

91.14

1.9

1.7

0.23

g/l

0.20

1885

9261

Pulmonary embolism

691

3030

2.35

91.08

1.8

1.6

0.25

0.23

g/l

4.18

650

2853

Nausea and vomiting

671

2846

2.37

90.67

1.8

1.6

0.24

0.23

g/l

1.55

630

2715

Visual disturbances and blindness

1235

6715

1.88

90.14

1.9

1.7

0.23

g/l

0.13

1173

6350

Spondylopathies (FG)

343

1058

3.36

89.90

1.7

1.2

0.23

0.24

g/l

0.66

324

996

Shoulder lesions

1621

5636

1.77

89.59

1.7

1.6

0.24

0.23

g/l

0.23

1538

5330

Other arrhythmias

1427

6034

1.81

89.56

1.8

1.6

0.23

g/l

0.46

1358

5715

Mycoses

689

3044

2.34

89.54

1.9

1.7

0.23

g/l

0.42

658

2878

Other noninfective gastroenteritis and colitis

658

2848

2.38

89.52

1.8

1.7

0.23

g/l

0.10

627

2700

Rosacea

384

1279

3.17

89.34

2.2

1.8

0.22

0.23

g/l

1.90

364

1207

Pulmonary heart disease

691

3056

2.32

89.27

1.8

1.6

0.25

0.23

g/l

4.16

650

2876

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2255

9246

1.61

89.03

1.7

0.24

0.23

g/l

2.00

2133

8775

Visual disturbances

1165

6257

1.90

88.64

1.9

1.7

0.23

g/l

0.10

1106

5918

Peripheral artery disease

864

3273

2.15

88.63

1.5

0.24

g/l

0.69

824

3071

Tumor necrosis factor alpha inhibitors

490

1871

2.74

88.04

1.5

1.8

0.23

g/l

0.75

459

1770

Hypertensive Renal Disease

139

214

7.04

87.46

1.4

1.3

0.26

0.23

g/l

4.05

131

202

Seropositive rheumatoid arthritis, strict definition

441

1606

2.87

86.92

1.6

0.22

0.24

g/l

5.49

418

1511

Disorders of lipoprotein metabolism and other lipidaemias

1718

6276

1.72

86.60

1.5

1.6

0.25

0.23

g/l

18.17

1621

5951

Persons encountering health services for examination and investigation

1351

3662

1.87

86.38

1.8

1.5

0.23

0.24

g/l

0.56

1273

3496

Symptoms and signs involving the urinary system

1674

7568

1.71

86.12

1.7

1.6

0.24

0.23

g/l

0.72

1572

7192

Zoster [herpes zoster]

482

1842

2.72

86.11

2.5

1.5

0.23

0.24

g/l

2.02

455

1723

Conjunctivitis

1821

9270

1.67

86.04

1.9

1.7

0.23

g/l

0.14

1733

8794

Disorders of the thyroid gland

2157

8831

1.61

85.77

1.8

1.7

0.23

g/l

0.17

2037

8378

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2142

8604

1.62

85.71

1.8

1.6

0.23

0.24

g/l

0.78

2034

8151

Sleep apnoea

2100

8498

1.62

85.51

1.6

1.7

0.25

0.23

g/l

17.46

1995

8043

Hypothyroidism, other/unspecified

2052

8401

1.63

85.24

1.8

1.7

0.23

g/l

0.47

1925

7972

Budesonide

338

1068

3.28

85.16

1.6

1.4

0.22

0.24

g/l

2.05

316

1014

Other diseases of urinary system

2273

8101

1.60

84.56

1.8

1.7

0.23

g/l

0.04

2143

7707

Other nutritional deficiencies

1595

8935

1.71

84.43

1.6

1.8

0.26

0.23

g/l

34.25

1515

8482

Acquired haemolytic anaemia

136

216

7.23

84.28

3.6

1.4

0.19

0.24

g/l

8.26

122

206

Streptococcal septicaemia

248

648

4.02

84.01

2.2

1.5

0.25

0.23

g/l

1.64

229

615

Hypothyreosis and Thyroxine purchase for inclusion criteria

2122

8772

1.61

83.79

1.8

1.7

0.23

g/l

0.63

1991

8325

Dysphagia

582

2457

2.44

83.78

1.7

1.5

0.23

g/l

0.49

549

2331

Anxiety (asthma-related co-morbidities)

1489

6683

1.75

83.54

1.8

0.23

g/l

0.12

1416

6356

Continuous positive airway pressure

422

1257

2.91

83.53

1.7

1.5

0.25

0.23

g/l

2.95

388

1193

All anxiety disorders

1523

7038

1.74

83.40

1.8

0.23

g/l

0.46

1448

6693

Other arthrosis

1012

3576

1.99

83.26

1.7

1.5

0.24

g/l

0.29

965

3377

Migraine with aura and triptan purchases

508

2033

2.60

82.87

1.9

2.0

0.22

0.23

g/l

0.45

484

1931

Other and unspecified rosacea

302

915

3.51

82.53

2.3

1.8

0.22

0.23

g/l

1.47

283

864

Migraine without aura

590

2527

2.41

82.53

1.9

0.23

g/l

0.03

560

2414

Atherosclerosis, excluding cerebral and coronary sclerosis

794

2981

2.15

82.15

1.5

0.24

g/l

0.42

753

2797

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1376

7843

1.76

81.78

1.8

1.6

0.24

0.23

g/l

0.71

1291

7436

Diseases of the myoneural junction and muscle

342

1124

3.19

81.12

2.5

1.5

0.22

0.24

g/l

2.88

331

1060

Coxarthrosis [arthrosis of hip](FG)

877

3020

2.07

81.00

1.7

1.2

0.24

0.25

g/l

1.71

830

2849

Other functional intestinal disorders

1025

5021

1.93

80.98

1.8

1.7

0.23

g/l

0.37

967

4751

Other diseases of upper respiratory tract

2407

8125

1.56

80.28

1.7

0.23

g/l

0.27

2268

7720

Fungal Sepsis

162

316

5.60

80.13

1.8

1.5

0.25

0.24

g/l

0.54

148

301

Candidiasis

755

3621

2.15

79.98

1.9

1.8

0.23

g/l

0.78

712

3429

Vasomotor and allergic rhinitis

946

4814

1.97

79.89

1.6

1.8

0.23

g/l

0.50

889

4599

Sleep apnoea, including avohilmo

2208

8779

1.58

79.62

1.6

1.7

0.25

0.23

g/l

21.62

2096

8315

Other anxiety disorders

1166

5580

1.85

79.19

1.8

0.23

g/l

0.38

1109

5315

Other/unspecified rheumatoid arthritis

350

1184

3.09

78.98

2.0

1.5

0.21

0.24

g/l

10.01

326

1121

Sleep disorders (combined)

2524

8710

1.54

78.86

1.7

1.8

0.24

0.23

g/l

6.96

2391

8249

Other reaction to severe stress, and adjustment disorders

948

4957

1.96

78.45

2.1

1.8

0.23

g/l

0.47

899

4728

Cerebrovascular diseases

1519

6310

1.72

78.15

1.8

1.6

0.24

g/l

2.99

1444

5957

Other antidepressants

2280

7516

1.57

77.99

1.7

0.24

0.23

g/l

4.51

2180

7120

Disorders of sclera, cornea, iris and ciliary body

1271

7287

1.78

77.83

1.9

1.7

0.24

0.23

g/l

0.24

1197

6923

Disorders of other endocrine glands

1053

5619

1.88

77.44

2.0

1.7

0.24

0.23

g/l

1.70

988

5324

Hypermobility syndrome

205

499

4.42

77.19

1.7

1.2

0.22

0.24

g/l

1.65

192

464

Early onset COPD, excluding more controls

390

1409

2.84

77.05

1.6

1.4

0.24

g/l

0.25

366

1330

5-aminosalicylic acid

453

1770

2.63

76.87

1.6

1.4

0.22

0.24

g/l

2.96

425

1688

Other CVD (FINNGEN)

258

542

3.82

76.57

1.6

0.24

0.23

g/l

1.74

242

509

Atopic dermatitis, strict definition with reimbursement

757

3572

2.10

75.48

1.8

0.23

g/l

0.18

721

3409

Spondyloarthritis

425

1629

2.69

75.18

1.7

1.3

0.23

0.24

g/l

0.73

400

1537

Haemolytic anaemias

157

317

5.47

75.01

3.3

1.5

0.19

0.24

g/l

7.96

143

301

Other bacterial intestinal infections

458

1827

2.59

74.87

1.8

1.6

0.23

0.24

g/l

0.33

420

1732

Polyarthritis, unspecified

138

249

6.01

74.17

2.0

1.6

0.24

g/l

0.15

132

239

Disorders resulting from impaired renal tubular function

158

324

5.39

74.17

2.0

1.5

0.27

0.24

g/l

2.59

148

309

Implicit fungal Sepsis

151

297

5.56

74.07

1.8

1.5

0.24

g/l

0.63

137

284

COPD (mode)

528

1731

2.44

73.70

1.4

0.24

g/l

0.61

501

1626

Paroxysmal tachycardia

481

1624

2.54

73.45

1.8

1.7

0.24

0.22

g/l

3.98

451

1531

Persons encountering health services in other circumstances

932

4932

1.92

72.97

1.9

1.7

0.23

g/l

0.07

902

4667

Other disorders of kidney and ureter

356

1271

2.93

72.88

1.7

1.5

0.25

0.24

g/l

2.51

338

1204

Sequelae of external causes of morbidity and mortality

622

2874

2.23

72.54

1.6

1.7

0.24

0.23

g/l

1.71

586

2714

Hypertensive Heart Disease

449

1372

2.62

72.29

1.7

1.5

0.24

0.23

g/l

3.64

423

1301

Dizziness and giddiness

1651

8124

1.63

71.90

1.6

1.7

0.24

0.23

g/l

0.46

1554

7715

Somatoform disorder

463

1896

2.53

71.83

1.8

0.22

0.23

g/l

1.54

427

1796

Other bacterial intestinal infections

557

2473

2.32

71.55

1.7

0.23

g/l

0.04

508

2342

Primary_lymphoid and hematopoietic malignant neoplasms

545

2411

2.33

70.64

1.7

1.5

0.23

0.24

g/l

0.18

500

2278

Diverticular disease of intestine

1446

5520

1.70

69.96

1.6

0.24

g/l

0.10

1366

5222

Depression or dysthymia

1491

4921

1.70

69.84

1.7

0.24

0.23

g/l

0.48

1414

4670

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1138

6334

1.78

69.47

1.7

0.24

g/l

0.18

1057

6023

Recurrent or chronic depression

963

3625

1.90

69.32

1.8

0.23

g/l

0.12

921

3449

Follow-up examination after treatment for conditions other than malignant neoplasms

909

3147

1.94

69.00

1.8

1.6

0.23

0.24

g/l

1.11

852

3005

Type 2 diabetes, wide definition

1635

6491

1.63

68.67

1.4

1.7

0.26

0.23

g/l

32.21

1550

6127

Convulsions, not elsewhere classified

478

1994

2.42

68.32

2.0

1.6

0.22

0.23

g/l

0.85

441

1896

Viral pneumonia

325

1144

2.95

68.05

2.0

1.5

0.24

g/l

0.28

310

1087

Bacterial intestinal infections, IBD co-morbidities

457

1910

2.47

67.64

1.8

1.6

0.23

0.24

g/l

0.52

420

1805

Lumbar disc prolapse

1348

6182

1.70

67.63

1.6

1.7

0.23

0.24

g/l

0.17

1270

5871

Hyperlipidaemia, other/unspecified

763

3571

2.01

67.42

1.5

0.25

0.23

g/l

9.89

720

3373

Subjective visual disturbances

624

2980

2.15

66.94

2.0

1.7

0.23

g/l

0.05

592

2815

Biological medicines for asthma

115

196

6.77

66.67

1.6

1.5

0.24

g/l

0.07

110

187

Hyperkalaemia

164

375

4.62

66.59

1.5

1.4

0.26

0.23

g/l

2.14

151

361

Disorders of lens

1367

5090

1.70

66.53

1.9

1.6

0.24

g/l

0.12

1289

4821

L04AC Interleukin inhibitors

217

612

3.79

66.48

1.7

1.6

0.23

0.24

g/l

0.52

209

575

Pure hypercholesterolaemia

1444

5718

1.67

66.41

1.5

1.6

0.25

0.23

g/l

14.60

1363

5421

Disorders of synovium and tendon

1124

5665

1.77

66.39

1.7

1.6

0.23

g/l

0.14

1073

5366

Enterocolitis due to Clostridium difficile

280

921

3.17

66.29

1.8

1.5

0.24

g/l

0.27

256

872

Other disorders of white blood cells

192

499

4.13

66.19

1.9

1.6

0.22

0.24

g/l

2.15

177

471

Cystitis

1898

7290

1.57

66.17

1.8

1.7

0.23

g/l

0.45

1793

6923

Bronchiectasis

225

653

3.63

65.59

1.6

1.5

0.23

0.24

g/l

0.24

213

612

Other viral diseases

932

5102

1.85

65.22

2.0

1.8

0.23

g/l

0.11

884

4870

Cutaneous abscess, furuncle and carbuncle

631

3055

2.12

65.19

2.0

1.7

0.24

0.23

g/l

1.31

597

2895

Symptoms and signs involving speech and voice

764

3966

1.97

64.81

1.8

1.7

0.23

g/l

1.01

719

3734

Dermatitis due to substances taken internally

178

444

4.26

64.68

2.6

1.7

0.22

0.23

g/l

0.61

168

421

Ischaemic heart disease, wide definition

1527

5858

1.64

64.18

1.7

1.6

0.24

g/l

3.32

1457

5538

Obesity and other hyperalimentation

1455

8755

1.63

63.99

1.5

1.8

0.26

0.23

g/l

43.94

1383

8310

Adalimumab

305

1081

2.96

63.58

1.5

1.8

0.23

g/l

0.46

286

1020

Rotator cuff syndrome

1205

5084

1.72

63.51

1.6

0.23

0.24

g/l

0.19

1142

4802

Other diseases of lip and oral mucosa

915

5064

1.85

63.48

1.9

1.7

0.22

0.23

g/l

4.24

868

4791

Obesity

1447

8730

1.62

63.33

1.5

1.8

0.26

0.23

g/l

44.19

1375

8285

Insulin, combination of fast acting with intermediate-acting or long-acting

1248

6867

1.69

62.84

1.5

1.6

0.26

0.23

g/l

19.51

1180

6503

Primary biliary cholangitis (PBC)

113

8.38

62.66

1.9

1.1

0.21

0.25

g/l

4.36

105

Allergic rhinitis

773

4026

1.94

62.60

1.6

1.9

0.23

g/l

0.03

729

3873

Peripheral artery operations in Hilmo

278

940

3.05

62.40

1.6

1.4

0.24

g/l

0.14

265

885

Nonhereditary hypogammaglobulinemia

120

9.02

62.39

2.9

1.4

0.24

0.23

g/l

0.25

114

Unspecified haematuria

844

3755

1.90

62.33

1.6

1.5

0.25

0.24

g/l

2.29

800

3549

Hypo-osmolality and hyponatraemia

381

1512

2.58

62.11

1.8

1.5

0.22

0.23

g/l

2.21

359

1426

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1251

7591

1.67

61.85

1.8

1.6

0.24

0.23

g/l

0.31

1172

7190

Pain in thoracic spine

389

1574

2.55

61.82

1.9

1.7

0.23

0.24

g/l

1.48

371

1495

ILD-related respiratory insufficiency

122

235

5.66

61.30

2.3

1.4

0.23

0.24

g/l

0.42

115

226

Cardiomyopathy

354

1376

2.64

60.93

1.5

1.4

0.23

0.24

g/l

0.81

331

1290

Other respiratory disorders and diseases

441

1900

2.38

60.82

1.6

1.5

0.24

g/l

0.88

412

1801

Other diseases of the respiratory system

441

1900

2.38

60.82

1.6

1.5

0.24

g/l

0.88

412

1801

Rash and other nonspecific skin eruption

283

987

3.00

60.70

2.3

1.7

0.23

0.24

g/l

0.81

271

933

Other gastritis (incl. Duodenitis)

498

2261

2.26

60.64

1.7

1.6

0.23

0.24

g/l

0.18

469

2134

Hypothyroidism, strict autoimmune, 3 medication purchases required

1856

8266

1.54

60.50

1.8

0.23

g/l

0.17

1747

7845

Insulin, fast-acting

791

4252

1.90

60.08

1.5

1.7

0.25

0.23

g/l

9.20

749

4039

Chronic gastritis

570

2738

2.13

60.00

1.8

1.5

0.23

0.24

g/l

1.90

539

2577

Insulin medication

1248

6381

1.67

59.83

1.5

1.7

0.26

0.23

g/l

25.18

1180

6046

Amputation

237

750

3.28

59.82

1.6

1.4

0.25

0.24

g/l

0.54

223

707

Diagnoses used for exclusion with ILD

558

2667

2.14

59.60

1.6

0.23

0.24

g/l

0.25

537

2515

Reactive arthropathies, FINNGEN

180

483

3.89

58.76

2.6

1.1

0.23

0.24

g/l

1.48

173

456

Mycoses

1845

10728

1.51

58.71

1.8

1.7

0.23

g/l

1.15

1752

10173

Thyroiditis, ILD-related definition

302

1108

2.83

58.70

2.1

1.3

0.22

0.24

g/l

3.79

292

1044

Temporomandibular joint disorders, including avohilmo

1081

6327

1.72

58.51

1.9

1.8

0.23

g/l

0.97

1027

6017

369

1500

2.55

58.24

1.8

0.25

0.23

g/l

2.70

345

1425

Benign neoplasm of colon, rectum, anus and anal canal

1236

6563

1.66

58.22

1.6

0.24

g/l

0.09

1174

6194

Papulosquamous disorders

860

4804

1.83

57.87

1.6

1.7

0.25

0.23

g/l

3.46

821

4543

Later onset COPD, excluding more controls

336

980

2.71

57.60

1.3

0.24

0.23

g/l

0.95

319

909

Other viral diseases

719

3795

1.93

57.53

2.0

1.8

0.23

g/l

0.24

682

3618

Fibrosis and cirrhosis of liver

218

676

3.40

57.34

1.5

0.20

0.24

g/l

6.86

203

644

Any mental disorder

2350

8132

1.46

57.13

1.8

1.7

0.24

0.23

g/l

1.09

2229

7724

Allergic urticaria

252

853

3.10

57.10

1.9

1.8

0.24

0.23

g/l

1.25

242

802

Intracranial trauma

1138

4766

1.70

56.94

1.8

1.7

0.23

g/l

1.63

1075

4525

Inflammatory diseases of the central nervous system

246

826

3.13

56.53

3.5

1.6

0.22

0.23

g/l

2.03

230

781

Drug-induced osteoporosis with pathological fracture

155

7.05

56.46

2.6

1.4

0.23

g/l

0.03

146

Gonarthrosis

1121

3751

1.72

56.44

1.5

0.24

g/l

0.79

1064

3542

Noninfectious colitis NAS

357

1454

2.54

56.14

1.9

1.7

0.23

g/l

0.03

349

1381

Candidiasis

368

1523

2.51

56.01

1.8

0.23

g/l

0.34

349

1437

Other enthesopathies

634

3250

1.99

55.72

1.7

1.6

0.24

0.23

g/l

0.81

606

3073

Cellulitis

508

2406

2.17

55.72

2.0

1.6

0.24

0.23

g/l

1.95

487

2274

Anaemia in chronic diseases classified elsewhere

104

190

6.07

55.61

2.1

1.4

0.25

0.23

g/l

1.58

180

Insulin, fast-acting or short human

793

4373

1.85

55.53

1.5

1.7

0.25

0.23

g/l

8.35

751

4151

Insulin, intermediate and long-acting

1088

6374

1.68

55.16

1.4

1.6

0.26

0.23

g/l

18.23

1029

6034

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1265

7702

1.62

55.13

1.9

1.8

0.23

g/l

0.64

1196

7305

Respiratory insufficiency

165

433

3.93

55.11

1.6

1.3

0.25

0.23

g/l

1.18

152

402

Concussion

986

4687

1.74

55.07

1.8

1.7

0.23

g/l

0.86

930

4450

Reactive arthropathies

217

686

3.29

54.97

2.6

1.5

0.23

0.24

g/l

1.13

206

644

Juvenile arthritis (FINNGEN)

150

373

4.26

54.75

2.6

1.2

0.20

0.23

g/l

3.79

145

347

Diaphragmatic hernia

753

4113

1.87

54.56

2.0

1.6

0.24

g/l

0.13

711

3888

Obesity due to excess calories

1079

6532

1.68

54.35

1.5

1.8

0.27

0.23

g/l

36.04

1032

6210

Other complications of surgical and medical care, not elsewhere classified

281

1037

2.83

54.23

1.7

0.24

0.23

g/l

0.14

269

982

Coronary atherosclerosis

1187

4561

1.67

54.22

1.7

1.5

0.24

g/l

1.18

1130

4313

Triptan medication for migraine, min. 3 purchases

1365

6621

1.60

53.95

1.8

1.9

0.22

0.23

g/l

2.66

1304

6303

Benign neoplasm: Colon

1045

5985

1.69

53.95

1.6

0.24

g/l

0.09

992

5644

Voice disturbances

619

3189

1.99

53.92

1.8

1.7

0.23

g/l

1.63

586

3008

Other neurological diseases

1441

7293

1.57

53.79

1.7

1.6

0.23

g/l

0.43

1358

6901

Allergic conjunctivitis

1320

8215

1.59

52.99

1.9

1.8

0.23

g/l

0.42

1247

7793

Idiopathic thrombocytopenic purpura

126

284

4.86

52.83

3.9

1.5

0.19

0.24

g/l

5.99

116

269

Myocarditis

128

290

4.62

52.48

2.0

1.6

0.23

0.24

g/l

0.31

122

277

Triptan medication for migraine, single purchase ok

1723

7815

1.51

52.40

1.8

0.23

g/l

2.42

1644

7429

Migraine, single triptan purchase ok & required. ICD-code if available is included

1723

7815

1.51

52.40

1.8

0.23

g/l

2.42

1644

7429

Peripheral arterial reconstruction

337

1377

2.52

52.38

1.4

0.25

0.23

g/l

2.01

323

1296

Hernia of abdominal wall, postoperative

345

1426

2.47

52.12

1.5

0.24

g/l

0.54

316

1373

Pain and other conditions associated with female genital organs and menstrual cycle

546

2493

2.07

52.03

1.9

0.22

0.23

g/l

0.16

514

2358

Other or ill-defined heart diseases

149

382

4.09

51.96

1.9

1.5

0.23

0.24

g/l

0.43

139

362

Other diseases of arteries and capillaries

221

731

3.15

51.95

1.7

1.6

0.23

0.24

g/l

0.32

204

688

Stroke, excluding SAH

1125

5013

1.66

51.88

1.7

1.5

0.24

g/l

1.53

1068

4726

Functional dyspepsia

598

3086

1.98

51.72

1.8

1.6

0.24

g/l

0.17

566

2923

Migraine without aura and triptan purchases

456

2140

2.20

51.50

1.8

2.0

0.22

0.23

g/l

0.32

435

2042

Stroke, including SAH

1194

5377

1.63

51.42

1.7

1.5

0.24

g/l

1.62

1132

5076

Amputation of toe

180

530

3.56

51.32

1.6

1.3

0.24

g/l

0.11

173

503

Other viral diseases, not elsewhere classified

648

3426

1.92

51.27

2.0

1.8

0.23

g/l

0.28

613

3268

Spinal stenosis

927

4101

1.74

51.24

1.5

1.6

0.24

g/l

0.09

877

3864

COPD

803

3693

1.81

50.87

1.4

1.6

0.24

g/l

0.63

757

3460

Internal derangement of knee

683

3675

1.88

50.83

1.7

1.6

0.24

g/l

0.34

650

3481

Cervicobrachial syndrome

496

2412

2.11

50.72

1.6

1.8

0.23

0.24

g/l

1.00

467

2280

Pruritus

274

1033

2.75

50.57

2.0

1.8

0.22

0.23

g/l

1.23

260

977

Other encephalitis

118

262

4.94

50.44

4.7

1.5

0.20

0.23

g/l

2.76

110

252

Inflammatory bowel disease

719

3978

1.84

50.08

1.6

1.7

0.23

g/l

0.74

677

3780

Other diseases of liver

433

2013

2.22

50.04

1.8

1.6

0.24

g/l

0.20

409

1906

Small fibre neuropathy

119

269

4.86

49.80

2.2

1.4

0.22

0.24

g/l

0.99

114

256

Dentofacial anomalies [including malocclusion]

1565

8393

1.52

49.74

1.8

0.23

g/l

0.96

1479

7971

Coeliac disease

326

1349

2.51

49.70

2.2

1.8

0.21

0.23

g/l

5.32

309

1283

Soft tissue disorders related to use, overuse and pressure

544

2757

2.01

49.49

1.9

1.6

0.24

0.23

g/l

0.08

507

2592

Constipation

1834

8716

1.47

49.34

1.7

0.23

g/l

0.56

1725

8277

Collagenous colitis

250

916

2.85

49.01

1.9

1.7

0.23

g/l

0.02

235

867

Carpal tunnel syndrome

1265

7156

1.58

48.98

1.5

1.7

0.24

0.23

g/l

0.19

1218

6770

Iridocyclitis

515

2575

2.05

48.91

1.9

1.7

0.23

0.24

g/l

0.08

492

2443

Sequelae of other external causes

176

530

3.51

48.70

1.5

1.6

0.25

0.24

g/l

0.73

165

503

Chronic apical periodontitis

2374

9689

1.41

48.68

1.7

0.24

0.23

g/l

2.18

2262

9174

Other skin changes

412

1899

2.23

48.59

1.8

1.6

0.23

0.24

g/l

0.93

393

1790

Encephalitis

121

283

4.66

48.41

4.6

1.6

0.20

0.23

g/l

2.90

113

272

Cervical disc disorders

714

3981

1.82

48.32

1.5

1.6

0.24

g/l

0.14

676

3778

Phlebitis and thrombophlebitis (not including DVT)

501

2495

2.06

48.10

2.0

1.6

0.24

g/l

0.21

473

2361

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1046

5144

1.65

47.96

1.4

1.6

0.26

0.23

g/l

24.23

990

4852

Disorders of muscles

242

879

2.85

47.95

1.7

1.6

0.23

g/l

0.03

236

829

Disorders of parathyroid gland

441

2070

2.16

47.92

2.1

1.5

0.24

g/l

0.52

409

1942

Psoriatic arthropathies

232

828

2.90

47.50

1.6

1.5

0.24

g/l

0.34

223

782

Idiopathic gout

214

732

3.04

47.48

1.5

1.4

0.27

0.24

g/l

3.12

208

690

Use of hypnotics and sedatives

2218

9061

1.42

47.47

1.7

0.23

g/l

0.15

2110

8588

Meniscus derangement

941

3765

1.70

47.33

1.6

1.5

0.24

g/l

0.36

898

3551

Coxarthrosis

817

3083

1.77

46.96

1.7

1.5

0.24

g/l

0.04

773

2913

Drug-induced cataract

108

238

5.04

46.83

3.1

1.5

0.21

0.24

g/l

1.70

102

225

Acute generalized exanthematous pustulosis

153

433

3.77

46.78

2.7

1.6

0.23

0.24

g/l

0.25

143

412

Cervicalgia

440

2112

2.13

46.61

1.7

0.23

0.24

g/l

0.90

419

1988

Ischaemic Stroke, excluding all haemorrhages

1027

4693

1.65

46.51

1.6

1.5

0.24

g/l

1.69

970

4417

Dermatopolymyositis, unspecified

14.83

46.49

1.8

1.1

0.21

0.25

g/l

1.81

Herpesviral [herpes simplex] infections

588

3135

1.92

46.27

2.0

1.7

0.22

0.23

g/l

1.60

561

2982

Major coronary heart disease event excluding revascularizations

1057

4344

1.64

46.01

1.7

1.5

0.24

g/l

2.18

998

4102

Senile cataract

1152

4430

1.61

45.97

1.8

1.5

0.24

g/l

0.10

1082

4189

Inflammatory diseases of female pelvic organs

1408

6866

1.53

45.75

1.9

0.23

g/l

0.19

1319

6514

Disorders of choroid and retina

1543

7404

1.50

45.46

1.7

1.6

0.24

g/l

1.12

1469

6999

Volume depletion

207

711

3.01

45.43

1.5

0.25

0.24

g/l

1.15

192

677

Other infectious diseases

226

819

2.87

45.14

2.0

1.6

0.24

g/l

0.31

210

771

GI-bleeding

602

3253

1.88

45.12

1.6

1.5

0.24

g/l

0.31

564

3072

Disorders of mineral metabolism

215

761

2.94

44.92

1.6

0.25

0.23

g/l

1.26

201

731

Other infectious diseases

195

654

3.11

44.88

2.0

1.5

0.24

g/l

0.03

182

620

Crohn disease

335

1472

2.35

44.57

1.6

1.8

0.23

g/l

0.00

317

1397

Scleritis and episcleritis

195

660

3.12

44.48

2.1

1.8

0.25

0.23

g/l

1.12

180

622

Unspecified privation

273

1096

2.58

44.46

1.7

1.6

0.24

0.23

g/l

0.11

261

1036

Other viral diseases, not elsewhere classified

452

2229

2.08

44.37

2.1

1.8

0.23

g/l

0.21

428

2120

Abnormal weight loss

230

851

2.81

44.23

2.1

1.5

0.23

g/l

0.33

221

808

Diseases of the ear and mastoid process

2473

9071

1.38

44.05

1.8

1.7

0.23

g/l

0.84

2344

8612

Factors influencing health status and contact with health services

530

1315

2.05

44.04

1.5

0.24

g/l

0.36

501

1254

Deforming dorsopathies

577

3106

1.89

43.90

1.8

1.7

0.23

g/l

0.97

538

2938

Benign neoplasms

2035

7968

1.42

43.65

1.8

1.7

0.23

g/l

0.23

1924

7593

Childhood asthma (age<16), excluding more controls

292

935

2.51

43.56

1.9

2.0

0.22

g/l

0.07

271

903

Sequelae with surgical and medical care as external cause

443

2190

2.08

43.54

1.6

0.24

g/l

0.60

418

2062

Abnormal results of function studies

227

844

2.80

43.25

1.8

1.6

0.23

0.24

g/l

0.62

217

801

Sarcoidosis

321

1404

2.36

43.20

1.6

0.24

g/l

0.46

309

1329

Weight loss

247

961

2.67

42.98

2.0

1.6

0.23

0.24

g/l

0.60

237

913

Unspecified acute lower respiratory infection

338

1513

2.30

42.88

1.7

1.6

0.23

g/l

0.03

319

1437

Presence of other functional implants

1082

4749

1.60

42.80

1.6

0.24

g/l

0.06

1018

4472

Pollen allergy

488

2481

1.99

42.67

1.7

1.9

0.22

g/l

0.31

459

2373

Childhood asthma (age<16)

292

945

2.49

42.65

1.9

2.0

0.22

g/l

0.08

271

914

Disorders of calcium metabolism

169

538

3.29

42.63

1.7

1.6

0.25

0.23

g/l

1.18

158

514

Agranulocytosis

282

1173

2.49

42.62

2.5

1.6

0.20

0.24

g/l

6.64

264

1113

Other disorders of veins

842

5066

1.68

42.57

1.6

1.7

0.23

0.24

g/l

0.13

803

4782

Other chronic obstructive pulmonary disease

741

3544

1.75

42.32

1.4

1.6

0.24

g/l

0.77

698

3319

Other external causes of accidental injury

1730

5988

1.46

42.30

1.8

1.7

0.24

0.23

g/l

2.53

1642

5709

Statin medication

1453

5493

1.50

41.89

1.8

1.7

0.25

0.22

g/l

22.12

1386

5205

Atopic dermatitis, strict definition

715

4076

1.75

41.85

1.8

1.9

0.23

g/l

0.06

680

3895

Erythema multiforme

210

5.01

41.85

2.6

1.4

0.21

0.23

g/l

1.67

201

Other diseases of the digestive system

595

3284

1.84

41.72

1.6

1.5

0.24

g/l

0.12

558

3102

Osteomyelitis

169

546

3.24

41.60

1.7

1.4

0.25

0.24

g/l

0.12

164

523

Accidents

1724

5988

1.46

41.41

1.8

1.7

0.24

0.23

g/l

3.17

1636

5709

Benzodiazepine use

2064

10285

1.39

41.39

1.7

0.23

g/l

0.22

1949

9759

Fall on same level

2402

9671

1.37

41.12

1.8

1.7

0.24

0.23

g/l

2.42

2273

9190

Oxicams

464

1292

2.07

41.05

1.8

0.23

g/l

0.43

445

1220

Generalized skin eruption due to drugs and medicaments

133

375

3.79

40.96

2.8

1.6

0.23

0.24

g/l

0.50

123

357

Myocardial infarction

828

3490

1.69

40.82

1.6

1.5

0.25

0.24

g/l

2.36

787

3290

Anterior Iridocyclitis

454

2320

2.01

40.67

1.9

1.7

0.23

0.24

g/l

0.49

432

2198

Hypokalaemia

266

1099

2.49

40.63

1.6

0.24

0.23

g/l

0.54

249

1040

Adrenocortical insufficiency

130

364

3.83

40.55

1.5

1.6

0.24

0.23

g/l

0.61

117

346

Other retinal disorders

1168

5977

1.54

40.00

1.7

1.6

0.24

g/l

1.04

1109

5632

Other disorders of patella

344

1596

2.20

39.84

1.8

1.6

0.23

0.24

g/l

0.52

324

1507

Abnormalities of gait and mobility

266

1111

2.47

39.75

1.5

0.24

g/l

0.01

254

1050

Disorders of gallbladder, biliary tract and pancreas

1987

9054

1.40

39.68

1.7

0.24

0.23

g/l

7.42

1878

8584

Other embolism and thrombosis

291

1265

2.37

39.68

2.2

1.6

0.24

g/l

0.07

276

1189

Exposure to other specified factors

1560

10037

1.44

39.46

1.9

1.7

0.23

g/l

0.06

1483

9533

Monoarthritis, not elsewhere classified

114

295

4.06

39.43

1.3

1.5

0.23

0.24

g/l

0.51

107

281

Acute and subacute iridocyclitis

424

2139

2.03

39.42

1.8

1.7

0.23

0.24

g/l

0.35

403

2029

Conjunctivitis (acute, non atopic)

615

3482

1.79

39.29

1.9

1.7

0.23

g/l

0.05

583

3320

Selective serotonin reuptake inhibitors

2009

7562

1.40

39.16

1.7

0.24

0.23

g/l

2.42

1904

7165

Non-selective monoamine reuptake inhibitors

747

4314

1.69

39.01

1.6

1.7

0.24

0.23

g/l

1.45

704

4072

Diplopia

300

1333

2.32

38.91

1.7

0.23

0.24

g/l

1.08

288

1258

Pneumonia due to other infectious organisms, not elsewhere classified

106

266

4.25

38.47

2.0

1.5

0.24

g/l

0.01

253

Other dermatomyositis

13.00

38.36

1.5

1.1

0.20

0.25

g/l

2.41

Suggestive for eosinophilic asthma

217

841

2.67

38.08

1.5

1.6

0.24

g/l

0.26

210

794

Other symptoms and signs involving cognitive functions and awareness

839

4733

1.64

38.03

1.7

1.6

0.23

0.24

g/l

1.44

772

4479

Exclusions for E4_PCOS_BROAD

407

2054

2.03

37.82

1.7

0.24

0.23

g/l

0.39

385

1952

Other cataract

808

3732

1.66

37.77

2.0

1.5

0.24

g/l

0.24

767

3519

Other disorders of adrenal gland

147

466

3.35

37.65

1.5

1.6

0.24

0.23

g/l

0.39

134

443

Herpesviral [herpes simplex] infections

285

1258

2.34

37.62

2.0

1.6

0.23

g/l

0.71

269

1184

Diabetes mellitus

2092

8977

1.37

37.44

1.5

1.8

0.25

0.23

g/l

37.04

1991

8508

All influenza (not pneumonia)

308

1404

2.25

37.37

1.8

1.6

0.23

0.24

g/l

0.94

287

1334

Psychiatric diseases

2005

7286

1.39

37.35

1.7

0.24

0.23

g/l

0.50

1910

6910

Diabetes, varying definitions

2080

8950

1.37

37.31

1.5

1.8

0.25

0.23

g/l

37.00

1980

8481

Presence of cardiac and vascular implants and grafts

748

3335

1.69

37.19

1.6

1.5

0.24

g/l

0.34

697

3137

Diabetic retinopathy, excluding more controls

509

1501

1.94

37.19

1.4

1.6

0.26

0.25

g/l

1.68

488

1435

Conduction disorders

507

2214

1.89

37.10

1.5

0.23

0.24

g/l

0.31

472

2067

Enthesopathies of lower limb, excluding foot

456

2407

1.93

37.02

1.7

0.24

g/l

0.04

428

2283

Hallux valgus (acquired)

578

2317

1.82

37.02

1.7

1.5

0.23

0.24

g/l

2.44

546

2178

Stomatitis and related lesions

445

2334

1.95

37.00

2.0

1.7

0.23

g/l

1.03

417

2217

Haemorrhage, not elsewhere classified

209

4.56

36.83

2.1

1.5

0.23

0.24

g/l

0.11

199

Chronic diseases of tonsils and adenoids

1599

7138

1.43

36.57

1.7

0.23

g/l

1.46

1522

6799

Other symptoms and signs involving the circulatory and respiratory systems

157

525

3.10

36.33

2.1

1.5

0.23

g/l

0.03

145

496

Etanercept

186

685

2.84

36.33

1.6

1.7

0.22

0.23

g/l

0.94

172

643

Lichen simplex chronicus and prurigo

154

511

3.14

36.24

1.5

1.6

0.24

g/l

0.09

144

489

Other erythematous conditions

111

301

3.93

36.20

2.0

1.6

0.24

g/l

0.07

106

288

Recurrent aphthous stomatitis , including avohilmo

335

1603

2.15

36.15

2.0

1.7

0.22

0.23

g/l

1.05

317

1518

Adjustment and management of implanted device

336

1609

2.13

35.94

1.5

0.24

0.23

g/l

0.49

313

1511

Coxibs

532

1501

1.89

35.92

1.7

1.8

0.23

g/l

0.11

500

1423

COPD, hospital admission 2, with asthma infections

547

2622

1.82

35.91

1.4

1.5

0.24

g/l

0.56

509

2468

Paracetamol or NSAID medication

330

742

2.27

35.48

1.5

1.7

0.24

0.22

g/l

1.51

316

705

Obesity, other/unspecified

756

4670

1.65

35.44

1.6

1.8

0.26

0.23

g/l

20.66

712

4451

Protozoal diseases

105

279

4.06

35.43

2.0

1.4

0.23

g/l

0.09

265

IBD patients in KELA-register

500

2760

1.85

35.33

1.6

1.8

0.23

g/l

1.29

474

2633

Other disorders of eye and adnexa

340

1651

2.12

35.31

1.8

0.24

0.23

g/l

0.45

320

1559

Neoplasms

1612

6045

1.43

35.22

1.8

0.23

g/l

0.71

1531

5786

Allergic contact dermatitis

303

1408

2.21

35.20

1.5

1.8

0.24

0.23

g/l

0.84

286

1337

Ulcerative colitis, NAS

325

1558

2.14

34.88

1.6

1.7

0.22

0.24

g/l

2.51

305

1479

Trochanteric bursitis

295

1364

2.22

34.67

1.7

1.6

0.24

0.23

g/l

0.44

276

1284

Missing teeth due to accident, extraction or parodontitis

1097

6971

1.50

34.21

1.8

1.6

0.23

0.24

g/l

0.99

1041

6592

Other shoulder lesions

216

879

2.53

34.21

1.7

0.24

0.23

g/l

0.35

203

829

Other diseases of anus and rectum

552

3156

1.77

34.21

1.8

1.6

0.23

g/l

0.49

520

2970

Nonorganic sleeping disorders, excluding more controls

419

2211

1.93

34.14

1.9

1.7

0.23

g/l

0.11

398

2108

Amyloidosis

174

4.91

34.08

1.6

1.4

0.24

0.23

g/l

0.34

167

Ocular pain

218

895

2.53

34.07

1.8

0.24

0.23

g/l

0.35

205

844

External causes of morbidity and mortality

1350

4650

1.47

34.06

1.8

0.24

0.23

g/l

1.73

1278

4450

Sequelae of cerebrovascular disease

611

3094

1.73

33.90

1.9

1.5

0.24

0.23

g/l

0.22

580

2910

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

114

330

3.67

33.77

2.3

1.5

0.22

0.24

g/l

1.89

107

311

Other diseases of intestine

287

1329

2.21

33.60

1.6

1.5

0.24

g/l

0.23

272

1255

Other and unspecified erythematous conditions

103

280

3.93

33.55

2.0

1.6

0.24

g/l

0.09

267

Pneumocystosis

174

4.95

33.38

2.0

1.4

0.24

0.23

g/l

0.38

165

Falls/tendency to fall

2252

8486

1.34

33.30

1.8

1.7

0.24

0.23

g/l

2.33

2136

8070

Cardiomyopathy, other and unspecified

162

579

2.89

33.26

1.6

1.5

0.23

0.24

g/l

0.75

150

546

Viral warts

236

1015

2.40

33.17

2.7

1.7

0.22

0.23

g/l

1.90

229

956

Other inflammation of eyelid

301

1433

2.16

32.94

2.2

1.5

0.22

0.24

g/l

2.14

280

1349

Inflammatory bowel disease, strict (require KELA)

500

2826

1.80

32.70

1.6

1.7

0.23

g/l

1.23

474

2691

Cardiomyopathies, Primary/intrinsic

218

909

2.46

32.62

1.4

0.24

g/l

0.15

199

854

Other metabolic disorders

311

1506

2.12

32.55

1.6

1.8

0.24

0.23

g/l

2.40

292

1427

Crohn's disease NAS

175

663

2.75

32.34

1.7

0.24

0.23

g/l

0.42

166

627

Psoriasis

563

3301

1.74

32.31

1.6

1.7

0.25

0.23

g/l

5.51

539

3126

Type 2 diabetes

1946

8449

1.36

32.29

1.5

1.8

0.26

0.23

g/l

38.32

1851

8003

Nonischemic cardiomyopathy

199

800

2.56

32.27

1.7

1.5

0.23

g/l

0.32

185

756

Other disorders of bone

425

2299

1.89

32.15

1.7

0.24

0.23

g/l

0.09

400

2181

Valvular operations

241

1057

2.33

32.10

1.7

1.4

0.23

0.24

g/l

0.29

227

990

Ulcerative colitis

511

2926

1.78

31.94

1.6

1.7

0.23

0.24

g/l

1.22

478

2786

Other and unspecified disorders of skin and subcutaneous tissue

150

528

2.95

31.82

2.2

1.5

0.22

0.24

g/l

1.71

143

503

Irregular menses

1086

5836

1.49

31.77

2.2

1.9

0.23

g/l

0.13

1030

5537

Other medical care

811

4679

1.58

31.77

1.4

1.6

0.24

0.23

g/l

0.63

777

4410

Non-invasive ventilation

405

1918

1.91

31.71

1.5

1.6

0.25

0.23

g/l

6.81

354

1825

Injury, poisoning and certain other consequences of external causes

1108

3726

1.50

31.62

1.8

1.7

0.23

g/l

0.42

1054

3553

Other inflammatory liver diseases

164

608

2.81

31.60

2.1

1.6

0.21

0.24

g/l

3.77

153

576

Misadventures to patients during surgical and medical care

313

1537

2.09

31.56

1.7

0.25

0.23

g/l

2.07

289

1456

Cardiomyopathy (excluding other)

223

956

2.39

31.38

1.4

0.24

g/l

0.21

204

898

Gastroduodenal ulcer

438

2404

1.84

31.13

1.7

1.5

0.24

g/l

0.34

407

2270

Other chronic obstructive pulmonary disease, including avohilmo

901

4899

1.54

31.08

1.5

1.6

0.24

g/l

0.44

849

4623

Other symptoms and signs involving the digestive system and abdomen

340

1732

2.00

30.81

1.9

1.6

0.22

0.23

g/l

0.74

317

1653

Angina pectoris

930

4084

1.53

30.71

1.6

1.5

0.24

g/l

2.29

881

3861

Keratitis

696

4364

1.62

30.70

1.9

1.7

0.24

0.23

g/l

0.19

654

4144

Multiple myeloma, including Hilmo

112

342

3.43

30.41

1.7

1.5

0.24

0.23

g/l

0.29

102

326

Systemic disorders of connective tissue in diseases classified elsewhere

12.68

30.34

1.5

1.2

0.23

g/l

0.15

Episcleritis

153

562

2.85

30.18

2.1

1.7

0.25

0.23

g/l

1.29

142

529

Myocardial infarction, without ST-elevation

635

3548

1.65

30.15

1.6

1.5

0.24

g/l

1.44

602

3333

DVT of lower extremities

361

1892

1.95

30.10

2.0

1.6

0.24

g/l

0.43

340

1784

Persons encountering health services for specific procedures, not carried out

201

841

2.47

30.10

1.7

0.24

0.23

g/l

0.45

185

791

Hyperparathyroidism

346

1768

1.97

30.01

1.9

1.5

0.24

g/l

0.76

318

1664

Vascular disorders of the intestines

139

484

2.96

29.96

1.9

1.5

0.24

g/l

0.09

130

454

Viral and other specified intestinal infections

575

3333

1.69

29.90

1.9

1.8

0.23

g/l

0.16

544

3189

COPD, hospital admissions

740

3979

1.59

29.86

1.4

1.5

0.24

g/l

0.55

696

3749

Injuries to the ankle and foot

1441

9295

1.39

29.85

1.9

1.7

0.23

g/l

0.98

1369

8832

COPD, early/later onset

746

4012

1.59

29.66

1.4

1.5

0.24

g/l

0.57

702

3779

Hypotension

292

1429

2.08

29.56

1.6

1.4

0.24

g/l

0.28

273

1341

Non-Hodgkin lymphoma, all, including Hilmo

260

1220

2.19

29.55

1.7

1.5

0.22

0.24

g/l

1.03

238

1154

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

121

396

3.24

29.53

1.7

1.6

0.24

g/l

0.08

106

372

Drug-induced adrenocortical insufficiency

201

4.39

29.47

1.7

1.6

0.25

0.24

g/l

0.42

194

Myocardial infarction, strict

722

3241

1.60

29.35

1.6

1.5

0.25

0.24

g/l

2.52

684

3053

Other and unspecified myopathies

178

712

2.58

29.33

1.3

1.4

0.24

g/l

0.11

170

675

AV-block

275

1145

2.14

29.30

1.4

0.24

g/l

0.01

254

1070

Other specified/unspecified soft tissue disorders

118

380

3.23

29.29

1.9

1.6

0.24

0.23

g/l

0.52

113

357

COPD related to multimorbidity

635

3305

1.64

29.24

1.4

1.5

0.24

g/l

1.00

596

3111

Iron deficiency anaemia secondary to blood loss (chronic)

311

1565

2.03

29.24

1.7

1.6

0.23

g/l

0.08

294

1466

Type 1 diabetes

507

2967

1.73

29.17

1.6

1.8

0.24

0.22

g/l

5.46

475

2820

Crohn's disease of small intestine

179

725

2.56

28.89

1.7

1.8

0.23

g/l

0.38

172

688

Covid-19 suspected case

476

2752

1.76

28.86

1.9

1.8

0.23

g/l

0.11

459

2609

Chronic laryngitis and laryngotracheitis

287

1411

2.08

28.85

1.9

1.7

0.23

g/l

0.81

269

1341

Multiple myeloma and malignant plasma cell neoplasms

115

370

3.25

28.69

1.8

1.5

0.24

g/l

0.05

104

354

Ovarian cyst

792

2936

1.58

28.67

1.9

1.8

0.23

g/l

0.12

753

2774

COPD, hospital admissions 3, with asthma pneumonia sepsis

439

2103

1.81

28.67

1.4

1.5

0.24

g/l

0.50

406

1984

Operations 2 for CAVS

456

2525

1.78

28.52

1.6

1.4

0.23

0.24

g/l

0.17

428

2362

Calcific aortic valvular stenosis, diagnosis (helper)

456

2525

1.78

28.52

1.6

1.4

0.23

0.24

g/l

0.17

428

2362

Injuries to the knee and lower leg

2370

10218

1.30

28.48

1.7

0.24

0.23

g/l

2.23

2257

9676

Localized swelling, mass and lump of skin and subcutaneous tissue

595

3661

1.65

28.42

1.8

1.7

0.23

0.24

g/l

2.05

570

3470

Other and unspecified disorders of white blood cells

115

374

3.24

28.29

2.1

1.5

0.21

0.24

g/l

2.41

104

354

Cerebral palsy and other paralytic syndromes

248

1164

2.19

28.25

1.9

1.6

0.24

0.23

g/l

0.52

232

1102

Calcific aortic valvular stenosis

456

2534

1.77

28.19

1.6

1.4

0.23

0.24

g/l

0.15

428

2370

Calcific aortic valvular stenosis, operated

456

2534

1.77

28.19

1.6

1.4

0.23

0.24

g/l

0.15

428

2370

Injuries to the thorax

807

5333

1.53

28.08

1.7

1.6

0.24

g/l

0.61

759

5045

Calcific aortic valvular stenosis, including rheumatic fever

457

2543

1.77

28.02

1.6

1.4

0.23

0.24

g/l

0.13

429

2378

Brachial plexus disorders

231

1059

2.25

28.01

1.5

1.9

0.23

g/l

0.04

226

998

Abnormal findings on diagnostic imaging of other body structures

286

1422

2.06

27.93

1.8

1.6

0.23

g/l

0.10

272

1344

Scleritis

129

5.26

27.93

1.8

1.4

0.23

0.24

g/l

0.47

124

Other CVD

338

1777

1.94

27.89

1.6

1.5

0.24

g/l

0.69

316

1668

Pacemaker

517

2949

1.70

27.84

1.4

1.5

0.23

0.24

g/l

0.19

479

2771

Gastric ulcer

305

1551

2.00

27.76

1.7

1.5

0.24

g/l

0.02

282

1465

Special screening examination for infectious and parasitic diseases

455

1903

1.78

27.67

1.9

1.7

0.22

0.24

g/l

2.22

429

1828

Chronic tubulo-interstitial nephritis

297

3.49

27.66

1.5

1.8

0.25

0.22

g/l

1.77

285

Polyuria

409

2291

1.82

27.64

1.8

1.5

0.23

0.24

g/l

0.80

385

2167

Other Crohn's disease

178

736

2.51

27.49

1.7

0.24

0.23

g/l

0.49

168

695

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1810

8225

1.34

27.45

1.4

1.7

0.26

0.23

g/l

37.31

1714

7797

Diabetic maculopathy, excluding more controls

222

1008

2.26

27.44

1.4

1.6

0.26

0.23

g/l

5.38

213

950

Hypoparathyroidism

107

340

3.33

27.43

2.7

1.6

0.23

g/l

0.14

323

Other enthesopathy of foot (+metatarsalgia)

216

971

2.28

27.37

2.0

1.7

0.23

g/l

0.11

205

916

Sacroiliitis, not elsewhere classified

128

451

2.95

27.21

1.6

1.9

0.24

0.23

g/l

0.37

119

422

Acute nephritic syndrome

194

4.22

27.21

2.4

1.4

0.25

0.23

g/l

0.71

184

Radiculopathy

295

1496

2.01

27.13

1.6

0.24

g/l

0.01

280

1411

Diseases of pulp and periapical tissues, including avohilmo

2098

8350

1.31

27.07

1.7

0.24

0.23

g/l

2.12

1996

7915

Diseases of tongue

145

547

2.75

27.02

2.1

1.5

0.23

0.24

g/l

0.34

135

516

Erythema nodosum

255

3.70

26.85

1.9

1.6

0.24

g/l

0.04

242

Other/unspecified synovitis and tenosynovitis

231

1075

2.20

26.84

2.1

1.6

0.22

0.23

g/l

0.99

222

1011

Emphysema

141

526

2.76

26.76

1.7

1.4

0.24

g/l

0.35

134

492

Other follicular disorders

181

765

2.45

26.64

1.6

1.8

0.23

g/l

0.08

173

721

Behavioural syndromes associated with physiological disturbances and physical factors

1833

9905

1.32

26.61

1.7

0.23

g/l

0.37

1749

9388

Cytomegaloviral disease

239

3.83

26.56

2.1

1.5

0.25

0.23

g/l

0.61

228

Other/unspecified reactive arthropathies

164

664

2.57

26.55

2.6

1.6

0.23

0.24

g/l

0.50

157

629

Disorders of ocular muscles, binocular movement, accommodation and refraction

954

6546

1.46

26.45

1.8

0.23

g/l

0.06

892

6220

Disorder of lipoprotein metabolism, unspecified

228

1063

2.19

26.32

1.5

0.26

0.23

g/l

3.64

217

1010

Prurigo nodularis

185

4.20

26.27

1.3

1.5

0.24

g/l

0.22

179

Bullous disorders

133

488

2.83

26.22

1.8

1.5

0.22

0.23

g/l

0.87

126

462

Postprocedural endocrine and metabolic disorders, not elsewhere classified

278

1402

2.03

26.15

1.5

1.8

0.24

0.23

g/l

2.45

260

1334

Metatarsalgia

201

895

2.31

26.10

2.0

1.6

0.23

g/l

0.25

190

844

Seborrhoeic dermatitis

186

802

2.38

26.02

2.0

1.6

0.21

0.24

g/l

3.92

178

762

Dermatophytosis

261

1290

2.07

25.95

2.0

1.5

0.23

0.24

g/l

1.77

252

1216

Nonalcoholic fatty liver disease

226

1061

2.20

25.87

1.7

0.24

g/l

0.15

214

1006

Benign neoplasm of other and ill-defined parts of digestive system

352

1926

1.87

25.84

1.6

0.24

g/l

0.11

331

1811

Adhesive capsulitis of shoulder

300

1560

1.96

25.68

1.6

1.5

0.24

g/l

0.61

286

1471

Other diseases of oesophagus

188

819

2.36

25.67

2.2

1.5

0.23

0.24

g/l

1.06

179

778

Other diseases of blood and blood-forming organs

155

621

2.58

25.62

1.9

1.6

0.24

g/l

0.17

141

589

Endometriosis

748

2859

1.56

25.61

1.7

1.8

0.23

g/l

0.13

709

2701

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

276

1398

2.02

25.59

1.4

1.5

0.21

0.24

g/l

4.99

258

1323

Hyperkinetic disorders, excluding more controls

257

1211

2.08

25.55

1.8

1.9

0.22

g/l

0.19

244

1166

Amputation of foot

198

4.03

25.53

1.4

1.3

0.23

0.24

g/l

0.32

190

Algoneurodystrophy

103

336

3.24

25.31

1.5

1.6

0.23

0.24

g/l

0.26

314

Retention of urine

553

2801

1.64

25.30

1.5

0.24

g/l

0.28

506

2637

Disorders of vitreous body and globe

908

6028

1.46

25.26

1.6

0.24

g/l

0.14

850

5691

Transient ischemic attack

865

4771

1.48

25.22

1.7

1.5

0.23

0.24

g/l

0.14

815

4493

Crohn disease (strict definition, require KELA)

166

693

2.49

25.18

1.7

0.24

0.23

g/l

0.16

160

649

Infective dermatitis

214

992

2.21

25.15

1.6

0.23

0.24

g/l

0.37

199

938

Disorders of vitreous body

886

5901

1.47

25.00

1.6

0.24

g/l

0.12

829

5570

Superficial injury of lower leg

501

3055

1.67

24.94

1.7

0.24

0.23

g/l

0.84

467

2892

Diseases of oral cavity, salivary glands and jaws

1055

3787

1.44

24.92

1.6

1.5

0.24

0.23

g/l

0.26

989

3568

Epilepsy

545

3380

1.63

24.89

2.1

1.6

0.22

0.23

g/l

1.02

508

3215

Congenital malformations, deformations and chromosomal abnormalities

1296

8789

1.37

24.83

1.7

1.8

0.23

g/l

0.03

1241

8340

Lichen ruber planus, wide definition including periferal and oral lichen planus

427

2501

1.74

24.83

1.7

1.6

0.23

0.24

g/l

1.66

405

2360

Crohn disease (strict definition, require KELA, min 2 HDR)

164

686

2.48

24.78

1.7

0.24

0.23

g/l

0.23

158

642

Cirrhosis of liver, NAS

123

447

2.87

24.75

1.3

1.5

0.20

0.24

g/l

4.71

114

429

Personality disorders, excluding more controls

506

3099

1.66

24.68

1.8

0.23

g/l

0.38

473

2952

Open wound of lower leg

302

1597

1.93

24.67

2.0

1.6

0.23

0.24

g/l

0.37

287

1513

Cytomegalovirus infection, IBD co-morbidity

237

3.73

24.64

2.2

1.6

0.25

0.24

g/l

0.61

226

Lichen planus

258

1295

2.04

24.63

1.7

1.5

0.23

0.24

g/l

0.56

247

1226

Cerebral cysts

142

557

2.65

24.57

1.6

1.7

0.22

0.24

g/l

1.99

137

530

Dental caries, including avohilmo

1380

5174

1.37

24.55

1.6

0.23

g/l

0.17

1312

4880

Haemorrhoids and perianal venous thrombosis

545

3397

1.62

24.47

1.5

0.23

0.24

g/l

0.78

525

3188

Diseases of middle ear and mastoid

1141

6733

1.40

24.37

1.9

1.8

0.23

g/l

0.64

1085

6412

Oter anti-inflammatory and antirheumatic agents, non-steroids

376

1137

1.85

24.24

1.6

1.7

0.23

0.24

g/l

0.37

351

1073

Viral infections of the central nervous system

182

804

2.34

24.23

2.5

1.7

0.22

0.23

g/l

0.68

168

760

Artrosis, including avohilmo

1601

6599

1.34

24.20

1.6

1.7

0.24

0.23

g/l

1.52

1522

6241

Neuralgia and neuritis, unspecified

119

430

2.87

24.17

1.6

1.7

0.23

g/l

0.01

112

400

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

172

743

2.40

24.17

1.7

1.8

0.23

g/l

0.12

165

697

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

668

4395

1.54

24.03

1.7

0.24

0.23

g/l

0.33

627

4169

Diseases of external ear

628

4075

1.56

24.03

1.6

1.7

0.24

0.23

g/l

1.16

594

3866

Hernia

1766

9093

1.31

24.00

1.7

0.23

g/l

0.02

1658

8638

Polycystic ovarian syndrome, consortium definition

1518

6749

1.34

23.99

2.0

1.8

0.23

g/l

0.08

1432

6393

Complications of internal orthopaedic prosthetic devices, implants and grafts

385

2210

1.77

23.99

1.6

1.5

0.24

g/l

0.38

359

2065

Postprocedural disorders of nervous system

189

855

2.29

23.83

2.0

0.23

g/l

0.15

178

806

Viral infections of the central nervous system

171

741

2.38

23.83

2.6

1.7

0.23

g/l

0.46

157

698

Nummular dermatitis

152

624

2.50

23.78

1.4

1.5

0.24

g/l

0.07

145

598

Congenital malformations, deformations and chromosomal abnormalities

1184

8249

1.38

23.71

1.7

1.8

0.23

g/l

0.20

1133

7830

Viral warts

435

2593

1.71

23.71

2.3

1.7

0.22

0.23

g/l

2.27

413

2471

Diabetes, insulin treatment (Kela reimbursement)

1898

8887

1.30

23.70

1.4

1.7

0.26

0.23

g/l

34.86

1801

8430

COPD-related respiratory insufficiency

203

945

2.20

23.62

1.4

0.24

g/l

0.04

184

895

Sleep disorders

1742

9695

1.31

23.54

1.7

0.23

g/l

0.39

1659

9189

Excessive, frequent and irregular menstruation

830

3078

1.50

23.50

2.1

1.8

0.23

g/l

0.16

786

2911

Pneumonia derived septicemia

299

3.26

23.36

3.1

1.4

0.22

0.24

g/l

0.68

282

Other psoriatic arthropathies

224

1093

2.11

23.20

1.6

0.25

0.24

g/l

0.54

215

1029

Paralytic ileus and intestinal obstruction

423

2513

1.70

23.16

1.5

0.23

0.24

g/l

0.23

396

2359

Corns and callosities

138

549

2.59

23.15

2.1

1.5

0.22

0.24

g/l

1.44

130

524

Abnormal involuntary movements

270

1407

1.96

23.14

1.8

1.6

0.23

g/l

0.31

250

1330

Psoriatic arthropathies, ICD10

229

1128

2.09

23.12

1.6

0.24

g/l

0.48

220

1062

Vitreous haemorrhage

198

923

2.20

23.05

1.4

1.5

0.26

0.24

g/l

1.74

185

870

Injuries to the abdomen, lower back, lumbar spine and pelvis

706

4686

1.51

22.99

1.8

1.6

0.23

g/l

0.00

666

4427

Problems related to lifestyle

219

1062

2.11

22.97

1.8

1.7

0.23

0.24

g/l

0.22

212

1004

Deviated nasal septum

558

3557

1.59

22.96

1.6

0.24

g/l

0.32

524

3385

Diseases of pulp and periapical tissues and dental caries

1232

4593

1.38

22.96

1.7

1.6

0.24

0.23

g/l

1.16

1169

4326

Arterial embolism and thrombosis

112

402

2.87

22.93

1.5

1.4

0.25

0.24

g/l

0.33

105

382

Heartburn

215

1036

2.12

22.91

1.6

0.24

g/l

0.08

203

985

Ankylosing spondylitis

181

816

2.28

22.88

1.7

0.23

0.24

g/l

0.38

170

775

Other epidermal thickening

103

355

3.02

22.88

2.1

1.5

0.24

g/l

0.16

336

Trigeminal neuralgia

136

541

2.60

22.87

1.6

0.23

0.24

g/l

0.09

127

509

Abnormal serum enzyme levels

469

2798

1.66

22.86

1.8

1.5

0.23

0.24

g/l

0.57

444

2651

Fenamates

286

1009

1.96

22.79

1.7

1.9

0.23

g/l

0.22

273

954

Early onset COPD

390

2283

1.74

22.72

1.6

0.24

g/l

0.11

366

2160

Fracture of rib(s), sternum and thoracic spine

507

3176

1.62

22.62

1.7

1.6

0.24

g/l

0.54

479

2992

Impingement syndrome of shoulder

405

2398

1.71

22.57

1.8

1.5

0.23

0.24

g/l

0.76

389

2264

Substance abuse, excluding more controls

976

5929

1.42

22.55

1.6

1.7

0.24

0.23

g/l

2.64

922

5645

Other bursopathies

234

1172

2.04

22.42

1.8

1.6

0.24

g/l

0.00

221

1100

Chronic iridocyclitis

123

472

2.71

22.33

2.0

1.6

0.23

0.24

g/l

0.49

117

445

Arthropathic psoriasis

233

1171

2.04

22.23

1.6

0.25

0.24

g/l

0.91

223

1101

Other local infections of skin and subcutaneous tissue

210

1018

2.12

22.11

2.1

1.6

0.24

0.23

g/l

0.12

193

967

Psoriasis vulgaris

352

2019

1.78

22.11

1.5

1.6

0.26

0.24

g/l

5.13

339

1907

Other disorders of bladder

213

1037

2.10

22.10

3.5

1.5

0.23

0.24

g/l

1.63

199

984

Insomnia

1705

9628

1.30

22.05

1.7

1.8

0.23

g/l

0.20

1622

9129

Spirochaetal infections, other/unspecified

186

863

2.22

22.02

1.8

1.6

0.22

0.24

g/l

1.80

167

816

Other diseases of hard tissues of teeth

1026

3775

1.42

21.96

1.7

1.5

0.24

0.23

g/l

0.35

960

3557

Persons with potential health hazards related to communicable diseases

791

5434

1.46

21.93

2.1

1.8

0.24

0.23

g/l

1.57

757

5195

Type 1 diabetes, wide definition, subgroup 1

414

2485

1.69

21.90

1.5

1.7

0.24

0.22

g/l

3.33

386

2365

Generalized anxiety disorder

336

1908

1.79

21.86

1.7

1.9

0.22

0.23

g/l

0.15

321

1826

Nonorganic sleeping disorders

419

2530

1.69

21.81

1.9

1.8

0.23

g/l

0.15

398

2409

Other/unspecified cytomegaloviral diseases

203

3.78

21.76

2.0

1.4

0.25

0.24

g/l

0.65

193

Spondylolisthesis/Spondylolysis

328

1852

1.80

21.72

1.8

1.6

0.23

0.24

g/l

1.72

310

1751

Other hammer toe(s) (acquired)

268

1306

1.92

21.63

1.7

1.4

0.23

0.24

g/l

1.60

257

1229

Unspecified fall

909

6379

1.42

21.57

1.7

0.24

0.23

g/l

1.55

852

6043

Vitamin deficiency

116

441

2.73

21.46

2.3

1.6

0.21

0.23

g/l

1.48

107

416

Vitamin deficiency, wide

116

441

2.73

21.46

2.3

1.6

0.21

0.23

g/l

1.48

107

416

Other extrapyramidal and movement disorders in other diseases

430

2626

1.66

21.39

1.7

0.23

g/l

0.63

402

2473

Other and unspecified local infections of skin and subcutaneous tissue

198

952

2.13

21.34

2.1

1.6

0.24

0.23

g/l

0.32

181

905

Gingivitis and periodontal diseases

1951

7910

1.28

21.33

1.7

0.23

g/l

0.39

1850

7490

Persistent mood disorders

374

2206

1.72

21.24

1.7

0.24

0.23

g/l

0.14

344

2101

Other/unspecified enthesopathies, not elsewhere classified

163

727

2.30

21.16

1.7

1.6

0.24

g/l

0.30

157

683

Cluster headache, wide

338

2.99

21.16

1.8

1.6

0.23

0.24

g/l

0.60

320

Varicose veins

1068

5888

1.38

21.03

1.8

1.6

0.23

0.24

g/l

1.94

1017

5558

Amyloidosis, other/unspecified

156

4.13

21.00

1.3

1.4

0.24

0.22

g/l

0.44

149

Nonsuppurative otitis media

463

2489

1.63

21.00

1.9

0.22

0.23

g/l

0.37

450

2371

Lichen planus, including avohilmo

355

2073

1.74

20.98

1.6

0.23

0.24

g/l

1.15

336

1955

Lung cancer and mesothelioma

240

1052

1.98

20.92

1.4

0.24

g/l

0.78

225

978

Disorders of oesophagus in diseases classified elsewhere

189

3.78

20.85

2.2

1.3

0.23

g/l

0.03

181

Injuries to the head

2145

10549

1.26

20.80

1.7

0.23

g/l

0.69

2039

10002

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

733

3173

1.49

20.80

2.5

2.0

0.22

g/l

1.42

703

3012

Post-traumatic stress disorder

201

982

2.10

20.79

1.6

2.0

0.23

0.22

g/l

1.24

187

933

Other and unspecified tonsillitis

633

3550

1.52

20.78

1.7

1.8

0.24

0.23

g/l

3.13

601

3389

Cholelithiasis, broad definition with cholecystitis

1611

8403

1.30

20.62

1.7

0.25

0.23

g/l

8.18

1519

7957

Lesion of ulnar nerve

261

1398

1.90

20.60

1.7

1.6

0.23

0.24

g/l

0.63

251

1327

Need for other prophylactic measures

133

551

2.50

20.59

1.8

1.6

0.25

0.24

g/l

0.47

126

522

Suppurative and unspecified otitis media

717

4365

1.47

20.52

1.9

0.23

g/l

0.20

677

4171

Meningitis

120

475

2.62

20.48

2.8

1.5

0.22

0.24

g/l

1.33

110

448

Intestinal malabsorption

112

429

2.71

20.45

1.5

1.7

0.22

0.24

g/l

0.91

105

408

Acute pancreatitis

342

1990

1.75

20.41

1.7

1.6

0.25

0.23

g/l

1.73

329

1880

Other obstetric conditions, not elsewhere classified

745

3254

1.48

20.38

2.5

2.0

0.22

g/l

1.50

714

3089

Other/unspecified enthesopathies of lower limb, excluding foot

153

678

2.32

20.26

1.5

1.7

0.24

g/l

0.08

146

643

Panic disorder

309

1753

1.80

20.22

1.6

1.9

0.23

g/l

0.39

289

1676

Type 1 diabetes, wide definition

424

2618

1.64

20.10

1.5

1.7

0.24

0.22

g/l

3.62

395

2489

Cluster headache, strict

321

2.99

20.06

1.8

1.6

0.23

0.24

g/l

0.57

304

Other disorders of ear

1704

8739

1.28

20.00

1.7

0.23

g/l

0.69

1610

8287

627

3869

1.50

19.98

1.7

1.5

0.23

0.24

g/l

2.93

582

3639

Acute pharyngitis

289

1600

1.82

19.90

1.8

0.23

g/l

0.56

272

1529

Chronic pancreatitis

225

1162

1.98

19.87

1.4

1.5

0.24

g/l

0.28

211

1104

Special screening examination for other diseases and disorders

193

942

2.08

19.85

1.7

1.5

0.25

0.23

g/l

1.88

183

896

Crohn's disease of large intestine

127

525

2.51

19.80

1.7

0.23

g/l

0.06

120

496

Cervicocranial syndrome

206

1033

2.04

19.79

1.5

1.7

0.23

0.24

g/l

0.84

196

976

Viral and other specified intestinal infections

404

2416

1.65

19.76

2.0

1.8

0.22

0.23

g/l

0.30

380

2319

Infections with a predominantly sexual mode of transmission

629

4255

1.50

19.76

2.2

1.8

0.22

0.23

g/l

1.89

591

4070

Mucosal proctocolitis

262

1429

1.87

19.60

1.5

1.8

0.23

0.24

g/l

1.14

244

1356

Hydronephrosis

190

929

2.09

19.52

1.4

1.6

0.26

0.23

g/l

3.08

185

876

Acute lymphadenitis

140

608

2.38

19.52

2.5

1.6

0.22

0.23

g/l

0.89

135

570

Excessive attrition of teeth

1082

8066

1.35

19.50

1.8

0.23

g/l

2.41

1038

7654

Acute suppurative otitis media

533

3259

1.55

19.45

2.0

1.9

0.22

0.23

g/l

0.35

507

3123

Type 2 diabetes, definitions combined

1740

8037

1.28

19.35

1.5

1.7

0.26

0.23

g/l

36.67

1657

7613

Dental operations

1079

4063

1.37

19.34

1.6

0.24

0.23

g/l

0.30

1018

3831

Other noninfective disorders of lymphatic vessels and lymph nodes

340

2.89

19.24

1.7

1.6

0.24

0.23

g/l

0.19

319

Extrapyramidal and movement disorders

641

4381

1.48

19.21

1.6

0.23

0.24

g/l

0.85

603

4126

Tongue abnormality

133

569

2.42

19.21

2.2

1.6

0.23

g/l

0.19

125

542

Speech therapy

475

3054

1.58

19.12

1.9

1.6

0.24

g/l

0.20

448

2883

Suppurative and necrotic conditions of lower respiratory tract

113

449

2.60

19.11

2.0

1.4

0.24

g/l

0.13

105

428

Caries of enamel

1722

9819

1.27

19.11

1.8

1.7

0.23

g/l

1.59

1635

9332

Aortic valve malfunction, age under 60 years

191

946

2.07

19.09

2.1

1.6

0.24

g/l

0.34

175

902

Non-follicular lymphoma

171

812

2.16

19.08

1.7

1.5

0.22

0.24

g/l

1.72

155

772

Cholelithiasis

1540

8273

1.29

19.02

1.7

0.25

0.23

g/l

7.63

1452

7829

Fracture of lumbar spine and pelvis

363

2185

1.68

19.00

1.9

1.5

0.23

0.24

g/l

0.48

345

2044

Acute laryngitis and tracheitis

234

1222

1.92

18.94

1.9

1.8

0.23

g/l

0.48

221

1172

Neuromuscular dysfunction of bladder

173

828

2.14

18.91

1.9

1.5

0.23

0.24

g/l

0.69

156

785

Decubitus ulcer and pressure area

106

410

2.65

18.87

1.6

1.3

0.25

0.24

g/l

0.55

395

Disease of hard tissues of teeth, NOS

972

3688

1.39

18.73

1.8

1.6

0.23

0.24

g/l

0.14

918

3479

Other disorders of pigmentation

373

2.75

18.70

1.5

0.23

0.24

g/l

0.37

349

Type 2 diabetes, strict (exclude DM1)

1744

8094

1.27

18.69

1.5

1.7

0.26

0.23

g/l

36.30

1661

7671

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

192

960

2.05

18.68

1.6

0.24

g/l

0.25

177

909

Pain associated with micturition

231

1230

1.92

18.67

2.1

1.6

0.22

0.23

g/l

0.73

215

1162

Diabetic retinopathy

600

2503

1.52

18.64

1.3

1.5

0.26

0.25

g/l

1.53

572

2377

Endometriosis of pelvic peritoneum

354

2031

1.69

18.64

1.7

1.8

0.23

g/l

0.54

334

1910

Sub-endpoint used in defining T1D endpoints

517

3347

1.54

18.60

1.6

1.7

0.25

0.23

g/l

2.88

484

3184

Infections with a predominantly sexual mode of transmission

796

5298

1.41

18.56

2.1

1.9

0.22

0.23

g/l

1.57

747

5062

Benign neoplasm: Colon, unspecified

412

2581

1.62

18.54

1.7

1.5

0.24

g/l

0.09

388

2432

Fissure and fistula of anal and rectal regions

415

2606

1.61

18.46

1.7

1.6

0.24

g/l

0.18

390

2453

Seborrhoeic keratosis

349

2100

1.69

18.44

2.0

1.5

0.23

0.24

g/l

0.85

320

1981

Menorrhagia

701

2678

1.47

18.43

1.9

1.8

0.23

g/l

0.62

658

2527

Injuries to the hip and thigh

787

5086

1.41

18.35

1.7

1.6

0.24

0.23

g/l

0.45

750

4800

Visual field defects

161

760

2.17

18.28

2.0

1.6

0.23

0.24

g/l

0.42

149

717

Diseases of peritoneum

194

985

2.01

18.08

1.6

0.24

g/l

0.75

187

934

Left ventricular outflow tract obstruction (LVOTO), broad definition

203

1048

1.98

18.06

2.2

1.5

0.24

g/l

0.02

185

1000

Other acute skin changes due to ultraviolet radiation

297

2.95

17.95

2.2

1.5

0.22

0.24

g/l

1.37

286

Other and unspecified diseases of blood and blood-forming organs

235

3.23

17.78

2.2

1.6

0.25

0.23

g/l

0.67

225

Ganglion

369

2277

1.64

17.67

1.4

1.7

0.24

0.23

g/l

0.78

349

2160

Other disorders of eyelid

713

4801

1.43

17.65

1.6

1.5

0.24

g/l

0.02

677

4513

Caries of dentine, including avohilmo

1439

5697

1.30

17.65

1.7

0.23

g/l

0.21

1366

5382

Atypical facial pain

118

498

2.45

17.62

1.6

1.8

0.23

0.24

g/l

0.55

110

474

Cluster headache, wide,, including avohilmo

128

561

2.36

17.56

1.8

1.7

0.23

g/l

0.26

122

523

Diabetes medication

1956

9361

1.25

17.55

1.4

1.8

0.26

0.23

g/l

40.41

1854

8876

Tonsillectomy and adenotomy

1153

6091

1.33

17.49

1.8

1.9

0.22

0.23

g/l

1.66

1100

5815

Disorders of refraction and accommodation

524

3498

1.51

17.44

1.9

1.8

0.23

g/l

0.18

491

3332

Other and unspecified visual disturbances

201

1048

1.96

17.38

2.0

1.7

0.24

g/l

0.02

195

990

Acute pancreatitis (for exclusion)

342

2081

1.67

17.36

1.7

1.6

0.25

0.24

g/l

1.11

329

1967

Cluster headache, strict, including avohilmo

123

537

2.37

17.06

1.8

1.7

0.23

g/l

0.24

117

499

Cardiodefibrillation

533

3590

1.50

17.05

1.7

1.5

0.24

g/l

0.11

510

3374

Disorders of vestibular function (Vertigo)

804

5753

1.39

16.98

1.6

0.23

g/l

0.06

770

5425

Carrier of infectious disease

258

3.07

16.97

2.2

1.6

0.25

0.23

g/l

0.61

244

KRA_PSY_EATING, excluding more controls

185

940

2.00

16.97

2.0

1.9

0.21

0.22

g/l

0.09

178

897

Chorioretinal inflammation

258

3.04

16.90

2.0

1.6

0.23

0.24

g/l

0.38

245

Acne

223

1212

1.88

16.87

2.1

1.9

0.21

0.22

g/l

0.64

207

1156

Type 2 diabetes, definitions combined, including avohilmo

1739

8105

1.26

16.80

1.5

1.7

0.26

0.23

g/l

35.56

1657

7681

Injuries to the wrist and hand

1898

10660

1.24

16.78

1.7

0.23

g/l

0.02

1794

10119

Elevated blood glucose level

155

747

2.12

16.71

1.3

1.5

0.25

0.24

g/l

0.81

146

707

Pneumococcal septicemia

315

2.82

16.69

3.2

1.4

0.23

0.24

g/l

0.34

298

Otitis externa

415

2674

1.57

16.65

1.8

1.7

0.24

0.23

g/l

0.63

395

2533

Inflammatory disease of uterus

308

1853

1.69

16.49

2.0

0.23

g/l

0.25

283

1760

Synovial cyst of popliteal space [Baker]

132

601

2.25

16.44

1.5

0.24

g/l

0.23

126

564

FESS (DNB20)

249

1414

1.80

16.42

1.7

0.23

0.24

g/l

0.54

240

1337

Acetic acid derivatives and related substances

443

1468

1.58

16.30

1.5

1.8

0.23

g/l

0.20

419

1390

Superficial injury of head

418

2710

1.56

16.25

1.7

0.23

g/l

0.03

400

2561

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

357

2237

1.62

16.23

2.0

1.9

0.22

0.23

g/l

0.51

344

2131

Other and unspecified nerve root and plexus disorders, also in other diseases

355

2220

1.62

16.20

1.6

1.7

0.24

g/l

0.09

329

2105

Ethmoidectomy

255

1465

1.78

16.15

1.7

0.23

0.24

g/l

0.65

246

1385

Other diseases of pancreas

153

744

2.11

16.15

1.6

1.5

0.23

0.24

g/l

1.01

143

703

Supplementary factors related to causes of morbidity and mortality classified elsewhere

558

3846

1.47

16.14

1.8

1.7

0.23

g/l

0.04

529

3637

Otitis externa, unspecified

223

1232

1.85

16.13

1.7

0.24

0.23

g/l

0.52

212

1166

Aortic aneurysm

311

1844

1.67

16.11

1.5

0.24

g/l

0.25

292

1742

Unspecified/other endometriosis

212

1154

1.88

16.11

1.6

1.9

0.24

0.23

g/l

1.71

195

1089

Hereditary angioödema type 1

41.27

16.11

3.0

1.3

0.14

0.25

g/l

—

Lateral epicondylitis

233

1306

1.81

15.99

1.6

0.24

g/l

0.47

225

1236

Diabetic retinopathy, strict definition

314

1682

1.68

15.97

1.3

1.5

0.26

0.25

g/l

0.87

299

1599

Other or unspecified ileus, impaction or obstruction

282

1667

1.71

15.96

1.4

1.5

0.24

g/l

0.04

266

1566

Dental pulpitis, including avohilmo

1758

9222

1.24

15.90

1.7

1.8

0.24

0.23

g/l

1.60

1678

8765

Disorders of optic nerve and visual pathways

200

1074

1.91

15.89

1.9

1.7

0.23

g/l

0.04

190

1010

Retinal detachments and breaks

564

3909

1.46

15.82

1.5

1.6

0.24

g/l

0.04

538

3673

COPD, hospital admissions 1, only main diagnosis

503

2909

1.49

15.73

1.5

0.24

g/l

0.25

473

2740

Melanocytic naevi

545

3761

1.47

15.71

2.2

1.7

0.22

0.23

g/l

3.25

516

3579

Golimumab

332

2.69

15.60

1.6

1.7

0.22

0.24

g/l

0.92

315

Invasive ventilation

138

655

2.16

15.55

1.6

1.4

0.25

0.24

g/l

0.64

123

624

Restless leg syndrome

255

1482

1.75

15.53

1.7

0.23

g/l

0.17

243

1402

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

155

770

2.06

15.48

1.8

1.7

0.25

0.23

g/l

1.75

145

734

Autoimmune hyperthyroidism

101

421

2.45

15.43

1.6

1.2

0.22

0.25

g/l

1.88

399

Scoliosis

171

882

1.98

15.31

1.7

1.8

0.23

g/l

0.06

160

839

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

390

2.53

15.18

2.0

1.5

0.23

g/l

0.02

372

Delirium, not induced by alcohol and other psychoactive substances

182

959

1.93

15.12

1.9

1.4

0.22

0.24

g/l

1.41

172

902

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

500

3403

1.48

15.12

1.7

1.9

0.23

g/l

0.11

458

3241

Other sleep disorders

198

1077

1.87

15.04

1.9

1.6

0.23

g/l

0.09

187

1020

Oesophageal varices

326

2.67

15.04

1.4

1.5

0.20

0.24

g/l

2.55

308

Ascites

131

617

2.17

15.04

2.0

1.5

0.22

0.24

g/l

1.42

121

591

Ankylosing spondylitis, ICD10

176

924

1.95

15.00

1.6

1.7

0.23

0.24

g/l

0.21

165

876

Other female pelvic inflammatory diseases

319

1989

1.63

14.86

1.8

0.22

0.23

g/l

0.86

295

1881

Chondrocostal junction syndrome [Tietze]

364

2.57

14.86

1.5

1.6

0.24

g/l

0.04

347

Postmenopausal osteoporosis with pathological fracture

116

526

2.27

14.70

2.0

1.5

0.23

g/l

0.12

107

496

Disorders of continuity of bone

192

1044

1.88

14.68

2.1

1.6

0.22

0.23

g/l

0.69

182

983

Pyothorax

348

2.58

14.65

2.1

1.4

0.24

g/l

0.18

334

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

416

2449

1.53

14.61

1.8

1.9

0.22

g/l

0.94

395

2345

Injuries to the neck

419

2787

1.52

14.58

1.6

1.8

0.24

0.23

g/l

0.34

402

2651

Speech disturbances, not elsewhere classified

152

766

2.03

14.56

1.8

1.5

0.24

g/l

0.00

140

725

Procreative management

637

3808

1.41

14.50

1.8

0.23

g/l

0.05

592

3642

Hypopituitarism

145

721

2.06

14.47

1.8

1.5

0.24

g/l

0.12

139

689

Chondropathies

290

1780

1.66

14.39

1.8

0.24

0.23

g/l

0.18

272

1685

Intracranial injury

1005

7321

1.31

14.38

1.8

1.7

0.24

0.23

g/l

0.68

949

6943

Degeneration of macula and posterior pole

692

4003

1.39

14.33

1.7

1.5

0.23

0.24

g/l

0.74

649

3745

Nasal polyp

308

1919

1.63

14.32

1.5

1.6

0.24

g/l

0.02

295

1817

Abnormal blood-pressure reading, without diagnosis

382

2.48

14.28

1.9

1.6

0.24

0.23

g/l

0.75

361

Retinal vascular occlusion

185

1003

1.88

14.22

1.4

1.5

0.24

g/l

0.30

177

940

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

161

823

1.97

14.19

2.6

1.7

0.22

g/l

0.08

153

777

Diabetic neuropathy

202

1122

1.83

14.18

1.3

1.4

0.26

0.25

g/l

0.28

191

1064

Diseases of inner ear

910

6707

1.32

14.16

1.6

1.7

0.23

g/l

0.08

869

6328

Faecal incontinence

162

845

1.96

14.06

2.1

1.6

0.22

0.23

g/l

0.96

146

803

Any death

984

5403

1.31

14.05

1.4

1.6

0.24

g/l

0.07

911

5118

Type of accident

512

3571

1.45

13.99

1.9

1.7

0.23

g/l

0.08

485

3383

Dilated cardiomyopathy

190

1045

1.85

13.98

1.4

1.5

0.24

g/l

0.06

174

991

Other disorders of conjunctiva

240

1414

1.73

13.93

1.8

1.6

0.23

0.24

g/l

0.20

225

1335

Retinal vascular disorders

185

1010

1.86

13.91

1.4

1.5

0.24

g/l

0.28

177

947

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

711

5222

1.37

13.90

1.9

1.8

0.24

0.23

g/l

1.50

684

4990

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

329

2036

1.59

13.87

1.7

0.23

g/l

0.39

320

1933

Multiple myeloma

204

3.07

13.84

1.6

1.5

0.24

0.23

g/l

0.25

196

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

204

3.07

13.84

1.6

1.5

0.24

0.23

g/l

0.25

196

Benign neoplasm of other and unspecified endocrine glands

242

1433

1.72

13.83

1.5

1.6

0.25

0.24

g/l

1.24

220

1351

Benign neoplasm: Ascending colon

229

1337

1.74

13.76

1.4

1.5

0.25

0.24

g/l

0.98

217

1260

Benign neoplasm: Stomach

175

946

1.89

13.67

1.6

0.24

g/l

0.12

163

901

Substance abuse

976

7087

1.30

13.65

1.6

1.7

0.24

0.23

g/l

2.43

922

6757

Mental and behavioural disorders due to psychoactive substance use

1009

7260

1.30

13.57

1.6

1.7

0.24

0.23

g/l

2.08

954

6922

Viral meningitis

368

2.48

13.56

3.0

1.6

0.23

0.24

g/l

0.65

345

Barrett oesophagus

405

2.39

13.48

1.7

1.4

0.24

g/l

0.44

384

Phobic anxiety disorders

260

1577

1.67

13.45

1.6

1.8

0.23

g/l

0.31

253

1507

Actinic keratosis

532

3476

1.43

13.45

1.6

1.5

0.22

0.24

g/l

2.86

494

3262

Injuries to the shoulder and upper arm

1458

9514

1.24

13.44

1.7

1.6

0.23

g/l

0.15

1380

9024

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

563

3977

1.41

13.43

2.0

1.9

0.23

g/l

0.13

533

3798

Unstable angina pectoris

501

2747

1.45

13.42

1.7

1.5

0.25

0.23

g/l

2.05

466

2577

conjunctival haemorrhage

133

659

2.07

13.42

1.8

1.6

0.23

0.24

g/l

0.81

124

631

Bacterial, viral and other infectious agents

174

945

1.88

13.40

1.7

0.23

0.24

g/l

1.04

168

892

Transport accidents

808

5244

1.33

13.31

1.8

1.7

0.24

0.23

g/l

2.24

775

5006

Cholecystectomy

1247

8588

1.26

13.24

1.7

0.25

0.23

g/l

7.03

1176

8128

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

313

1934

1.59

13.23

1.7

0.23

g/l

0.42

305

1835

Pneumonia due to Streptococcus pneumoniae

317

2.56

13.21

1.7

1.4

0.23

0.24

g/l

0.20

302

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

912

6101

1.31

13.18

2.0

1.9

0.23

g/l

0.76

871

5783

Corneal ulcer

325

2094

1.57

13.17

1.7

0.24

0.23

g/l

0.21

308

1989

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

299

1893

1.60

13.10

1.5

1.7

0.22

0.23

g/l

1.77

280

1794

Anogenital herpesviral [herpes simplex] infection

142

728

2.00

13.09

2.4

2.0

0.21

0.23

g/l

1.33

134

686

Skin changes due to chronic exposure to nonionizing radiation

547

3595

1.42

13.09

1.6

1.5

0.23

0.24

g/l

2.62

505

3378

Ulcerative colitis (strict definition, require KELA)

307

1956

1.59

13.08

1.5

1.7

0.22

0.23

g/l

1.82

288

1855

Extreme obesity with alveolar hypoventilation

368

2.44

13.06

1.4

1.6

0.26

0.23

g/l

1.56

349

Disturbance of activity and attention

250

1485

1.68

13.06

1.8

1.9

0.22

g/l

0.16

238

1419

Glucagon-like peptide-1 (GLP-1) analogues

501

3529

1.44

13.03

1.3

1.7

0.27

0.23

g/l

19.95

475

3358

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

501

3529

1.44

13.03

1.3

1.7

0.27

0.23

g/l

19.95

475

3358

Otitis media, unspecified

222

1198

1.74

13.02

1.7

1.8

0.22

g/l

0.53

209

1144

Amenorrhoea

159

848

1.92

13.01

2.3

1.9

0.22

g/l

0.32

151

804

Other disorders of nervous system

125

614

2.09

12.96

1.4

1.5

0.24

g/l

0.23

114

584

Open wound of ankle and foot

185

1035

1.82

12.93

1.8

1.6

0.23

0.24

g/l

0.15

172

979

Secondary and unspecified malignant neoplasm of lymph nodes

143

737

1.98

12.92

1.4

1.5

0.24

0.23

g/l

0.41

135

697

Benign neoplasm: Transverse colon

178

986

1.84

12.87

1.6

1.5

0.25

0.24

g/l

0.80

169

931

Fibroblastic disorders

336

2190

1.55

12.87

1.6

1.5

0.23

g/l

0.15

319

2056

Lung diseases due to external agents

204

1175

1.76

12.83

1.7

1.4

0.23

0.24

g/l

0.15

196

1112

Insulin, fast-acting (human)

258

1584

1.65

12.82

1.5

1.8

0.24

0.23

g/l

1.14

243

1503

Dislocation, sprain and strain of joints and ligaments at neck level

290

1834

1.61

12.79

1.6

1.8

0.24

0.23

g/l

1.28

279

1739

Viral encephalitis, not elsewhere classified/unspecified

204

2.99

12.71

2.6

1.4

0.22

0.23

g/l

0.73

197

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

517

3680

1.42

12.67

1.8

0.23

g/l

0.05

486

3509

Intestinal stricture

477

3347

1.44

12.65

1.6

0.23

0.24

g/l

0.27

444

3153

Thoracic aortic aneurysm

206

1196

1.75

12.64

1.4

1.5

0.24

g/l

0.23

192

1134

Other and unspecified disorders of vitreous body

677

4964

1.36

12.64

1.6

0.23

0.24

g/l

1.15

634

4686

Other contact dermatitis

142

736

1.97

12.61

1.8

0.23

g/l

0.29

134

695

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

326

2125

1.56

12.57

1.5

1.7

0.22

0.23

g/l

1.84

307

2018

Non-Hodgkin lymphoma, all

307

2.54

12.56

1.4

1.5

0.21

0.23

g/l

1.05

293

Thyrotoxicosis

453

3156

1.45

12.55

1.7

0.23

g/l

0.30

422

2977

Arthropathy in ulcerative colitis

138

3.49

12.51

2.2

1.4

0.21

0.24

g/l

1.38

133

Other disorders of the musculoskeletal system and connective tissue

251

1542

1.65

12.48

1.6

0.24

g/l

0.21

238

1456

Demyelinating diseases of the central nervous system

181

1019

1.82

12.47

1.8

1.9

0.23

g/l

0.31

174

958

Childhood allergy (age < 16)

294

1536

1.60

12.45

1.8

2.0

0.22

g/l

0.06

280

1477

Oral lichen planus, including avohilmo , including avohilmo

133

679

2.01

12.44

1.7

0.22

0.24

g/l

1.07

127

638

Olecranon bursitis

432

2.27

12.41

1.9

1.4

0.23

0.24

g/l

0.48

407

Personality disorders

506

3603

1.42

12.41

1.8

0.23

g/l

0.26

473

3452

Calcinosis cutis

18.38

12.40

1.8

1.5

0.24

0.23

g/l

0.26

Propionic acid derivatives

470

1622

1.47

12.40

1.5

1.8

0.24

0.23

g/l

0.72

448

1540

Anti-inflammatory and antirheumatic products, non-steroids

470

1622

1.47

12.39

1.5

1.8

0.24

0.23

g/l

0.59

447

1540

Cyst of kidney

122

604

2.07

12.39

1.4

1.5

0.25

0.24

g/l

0.57

116

573

Conductive and sensorineural hearing loss

1308

7116

1.25

12.32

1.6

0.23

0.24

g/l

1.84

1233

6739

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

15.42

12.21

1.5

1.1

0.22

0.23

g/l

0.09

Vitamin B12 deficiency anaemia

160

871

1.87

12.21

1.8

1.5

0.23

0.24

g/l

0.78

149

821

Acne vulgaris

168

930

1.84

12.21

2.0

1.9

0.22

g/l

0.16

158

886

Benign neoplasm: Sigmoid colon

297

1910

1.58

12.18

1.7

1.5

0.23

0.24

g/l

0.49

285

1798

Dermatophytosis

1048

8296

1.27

12.16

1.8

1.7

0.23

g/l

1.65

997

7885

Viral pneumonia (known virus, not influenza)

243

2.75

12.12

1.7

1.4

0.23

0.24

g/l

0.25

232

Plantar fascial fibromatosis

166

920

1.84

12.00

1.9

1.7

0.23

g/l

0.39

156

867

Lesion of lateral popliteal nerve

414

2.28

11.96

1.6

1.5

0.23

0.24

g/l

0.45

391

Spontaneous rupture of synovium and tendon

130

666

1.99

11.96

1.8

1.5

0.24

g/l

0.10

123

624

Non-allergic asthma

149

799

1.90

11.94

2.0

1.6

0.23

g/l

0.04

144

759

Trigger finger

227

1376

1.67

11.89

1.6

0.23

g/l

0.02

221

1301

Arthropathy in hypersensitivity reactions classified elsewhere

19.47

11.86

1.5

1.1

0.23

0.25

g/l

0.19

Arthropod-borne viral fevers and viral haemorrhagic fevers

311

2033

1.55

11.85

1.7

0.23

g/l

0.71

297

1919

Fracture of foot, except ankle

434

3035

1.45

11.81

1.9

1.7

0.23

g/l

0.15

410

2894

Thyroiditis

151

819

1.89

11.80

1.8

0.22

0.23

g/l

0.68

143

769

Benign paroxysmal vertigo

480

3418

1.42

11.79

1.7

1.6

0.24

0.23

g/l

0.19

460

3208

Impetigo

101

476

2.18

11.76

2.2

1.6

0.22

0.23

g/l

0.78

451

Other ulcerative colitis

116

576

2.06

11.73

1.5

1.6

0.22

0.24

g/l

1.49

104

544

Pneumothorax

111

544

2.08

11.58

1.7

1.4

0.24

g/l

0.09

105

518

Hyperkinetic disorders

258

1594

1.61

11.52

1.8

1.9

0.22

g/l

0.15

245

1522

Intestinal adhesions without obstruction

134

704

1.94

11.47

1.7

1.5

0.23

0.24

g/l

0.63

120

663

Congenital malformations of the urinary system

119

602

2.03

11.46

1.7

1.6

0.25

0.23

g/l

1.02

119

569

Hypercalcemia

384

2.31

11.46

1.8

1.5

0.25

0.23

g/l

0.52

364

Exclusions for E4_PCOS_CONSORTIUM

1405

7203

1.23

11.43

1.7

1.8

0.23

g/l

0.68

1341

6840

Appendectomy

1184

9159

1.24

11.40

1.7

0.24

0.23

g/l

0.82

1124

8699

D07AA Corticosteroids, weak (group I)

295

1924

1.55

11.34

1.6

1.8

0.24

0.23

g/l

1.16

278

1838

Left bundle-branch block

104

502

2.11

11.29

1.6

1.5

0.22

0.24

g/l

0.88

469

Sacrococcygeal disorders, not elsewhere classified

276

2.55

11.22

1.9

1.8

0.22

0.23

g/l

0.35

258

Familial hypercholesterolemia

211

1276

1.67

11.17

1.9

1.5

0.25

0.23

g/l

2.96

200

1208

Other specified/unspecified bacterial intestinal infections

120

614

2.00

11.17

1.8

1.5

0.22

0.24

g/l

1.01

110

580

Colonic or urogenital fistula

446

3168

1.42

11.15

1.9

1.7

0.24

g/l

0.15

418

3007

Fentanyl

144

780

1.87

11.13

1.4

1.5

0.24

g/l

0.01

134

739

Degenerative macular diseases

178

1031

1.75

11.09

2.1

1.5

0.23

0.24

g/l

0.95

168

961

Other noninflammatory disorders of vagina

156

871

1.83

11.09

2.6

1.8

0.22

0.23

g/l

0.40

147

815

Thyrotoxicosis, other and/or unspecified

345

2339

1.49

11.09

1.6

1.7

0.23

g/l

0.09

321

2218

Superficial injury of hip and thigh

230

1425

1.63

11.06

1.9

1.5

0.24

0.23

g/l

0.66

217

1337

Diabetic maculopathy

219

1263

1.66

11.05

1.4

1.5

0.26

0.25

g/l

0.85

211

1197

Acute gastritis

124

644

1.96

11.01

1.9

1.5

0.24

g/l

0.12

119

614

Use of pramipexole

355

2425

1.48

10.99

1.9

1.6

0.24

g/l

0.06

341

2280

Paralytic strabismus

118

604

1.99

10.96

1.5

0.24

g/l

0.10

113

573

Achilles tendinitis

169

969

1.77

10.93

1.7

1.6

0.23

0.24

g/l

0.47

161

921

Otalgia

156

876

1.82

10.90

1.5

1.7

0.23

g/l

0.06

148

828

Later onset COPD

356

1927

1.48

10.89

1.3

1.4

0.24

0.23

g/l

0.79

336

1806

Mononeuritis multiplex

12.63

10.82

1.8

1.6

0.21

0.24

g/l

0.42

Cryoglobulinemia

19.48

10.77

3.2

1.4

0.23

0.26

g/l

0.47

Strabismus

465

3341

1.40

10.73

1.6

1.8

0.23

g/l

0.25

433

3183

Unspecified misadventure during surgical and medical care

104

514

2.08

10.71

1.6

1.5

0.24

g/l

0.09

489

Dysplasia of cervi uteri

466

2417

1.41

10.61

2.5

1.8

0.22

0.23

g/l

1.10

435

2286

Aneurysms, operations, SAH

259

1669

1.57

10.60

1.9

1.6

0.24

g/l

0.58

246

1581

Ulcer of oesophagus

105

522

2.05

10.58

1.4

0.25

0.24

g/l

0.58

491

Other and unspecified types of non-Hodgkin lymphoma, hilmo

346

2.32

10.57

2.0

1.5

0.23

0.24

g/l

0.38

329

Substance use, excluding alcohol

341

2330

1.48

10.56

1.8

0.24

0.23

g/l

0.44

326

2225

Cerebral aneurysm, nonruptured

149

833

1.82

10.55

2.0

1.6

0.24

g/l

0.19

143

783

Bell's palsy

195

1175

1.68

10.54

1.6

0.25

0.24

g/l

1.73

180

1108

Vulvovaginal ulceration/inflammation in other diseases

135

734

1.89

10.54

1.7

2.1

0.22

0.23

g/l

0.61

129

690

Cardiac arrest

318

2.26

10.53

1.2

1.5

0.25

0.23

g/l

1.20

299

Pregnancy hypertension

814

5705

1.29

10.51

2.0

1.9

0.23

g/l

0.51

775

5411

Disorders of adult personality and behaviour

521

3839

1.37

10.47

1.8

0.23

g/l

0.20

485

3679

Sensorineural hearing loss

1208

6679

1.23

10.46

1.6

0.23

0.24

g/l

2.11

1135

6320

Injuries to unspecified part of trunk, limb or body region

175

1027

1.73

10.46

2.0

1.6

0.24

0.23

g/l

0.23

163

975

Sequelae of injuries, of poisoning and of other consequences of external causes

397

2796

1.44

10.46

1.6

1.7

0.24

g/l

0.81

379

2654

Endometriosis of rectovaginal septum and vagina

152

858

1.81

10.45

1.4

1.8

0.23

g/l

0.00

143

800

Other hearing loss

399

2751

1.43

10.40

1.7

1.5

0.23

0.24

g/l

0.31

376

2581

Endometriosis ASRM stages 1,2

358

2481

1.46

10.37

1.7

1.9

0.23

g/l

0.56

337

2353

Other and unspecified vaccines and biological substances

4.32

10.36

1.3

1.6

0.24

0.23

g/l

0.32

Adenomyosis (Endometriosis of uterus)

245

1569

1.58

10.35

1.8

1.7

0.23

g/l

0.11

235

1470

Cardiac murmurs and other cardiac sounds

159

900

1.77

10.33

1.9

1.7

0.23

0.22

g/l

0.02

151

860

Melanocytic naevi of trunk

212

1314

1.64

10.29

2.3

1.7

0.22

0.23

g/l

0.83

204

1240

Mouth breathing

655

4997

1.32

10.28

1.7

1.6

0.24

g/l

0.91

623

4757

Use of anticholinesterases

203

2564

0.62

10.26

1.3

1.4

0.23

g/l

0.01

184

2397

N06DA Anticholinesterases

203

2564

0.62

10.26

1.3

1.4

0.23

g/l

0.01

184

2397

Gluteal tendinitis

351

2.29

10.23

1.6

1.7

0.24

g/l

0.07

331

Gonarthrosis,primary

1452

7432

1.21

10.15

1.6

0.24

g/l

2.33

1369

7032

Specific personality disorders

429

3085

1.41

10.05

1.7

1.8

0.23

g/l

0.37

399

2951

Disorders of orbit

419

2.16

10.04

1.7

1.5

0.24

0.23

g/l

0.18

397

Myeloproliferative diseases

133

730

1.86

10.03

1.5

0.22

0.24

g/l

1.17

120

691

Lymphoid leukaemia

466

2.09

9.99

1.9

1.4

0.25

0.24

g/l

0.38

448

Other condition

249

1614

1.56

9.99

1.8

1.7

0.23

0.24

g/l

0.30

233

1529

921

6647

1.26

9.96

1.6

1.7

0.24

g/l

0.96

864

6334

Cholecystitis

210

1308

1.63

9.95

1.4

1.6

0.24

g/l

0.74

200

1234

Use of donepezil

1596

0.49

9.85

1.2

1.4

0.25

0.23

g/l

1.18

1487

Focal epilepsy

348

2420

1.45

9.83

2.2

1.7

0.22

0.23

g/l

0.86

330

2296

Injury of unspecified body region

135

750

1.83

9.80

2.1

1.6

0.23

g/l

0.03

124

712

Bacterial, viral and other infectious agents

152

875

1.77

9.78

1.7

1.6

0.23

0.24

g/l

0.99

146

827

Anogenital herpesviral [herpes simplex] infection

218

1379

1.61

9.77

2.3

1.9

0.21

0.23

g/l

2.39

203

1311

Periodontitis

1683

9524

1.19

9.74

1.8

1.7

0.24

0.23

g/l

1.91

1588

9033

Emotionally unstable personality disorder

245

1593

1.56

9.73

1.6

1.9

0.23

g/l

0.78

228

1517

Pleural plaque

118

629

1.90

9.71

1.7

1.3

0.23

0.24

g/l

0.04

111

596

Other disorders of optic [2nd] nerve and visual pathways

119

638

1.91

9.71

2.0

1.6

0.23

g/l

0.10

112

603

Noninflammatory disorders of female genital tract

798

3122

1.29

9.68

2.0

1.8

0.22

0.23

g/l

0.63

761

2955

Other (not insulin) diabetes medications

1697

8522

1.19

9.61

1.4

1.7

0.26

0.23

g/l

43.72

1608

8085

Atrophic disorders of skin

236

1525

1.57

9.61

1.9

1.6

0.24

0.23

g/l

0.91

225

1440

Alcohol use disorder, Swedish definition

857

6257

1.26

9.55

1.6

0.24

g/l

1.05

803

5961

Exposure to other and unspecified inanimate mechanical forces

133

742

1.83

9.55

1.6

0.23

g/l

0.18

123

705

Chronic periodontitis, including avohilmo

1675

9513

1.19

9.55

1.8

1.7

0.24

0.23

g/l

1.73

1580

9023

Viral haemorrhagic fevers, not elsewhere classified/unspecified

269

1790

1.52

9.55

1.7

1.6

0.23

g/l

0.96

256

1686

Hallux rigidus

182

1106

1.66

9.53

1.6

1.4

0.24

g/l

0.20

176

1041

Malignant neoplasm of breast, HER2-negative

460

4082

0.73

9.50

1.4

1.8

0.24

0.23

g/l

0.86

424

3866

Hernia of abdominal wall

714

5578

1.29

9.48

1.5

1.6

0.24

g/l

0.41

661

5294

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1082

6994

1.23

9.47

2.2

1.8

0.23

g/l

1.38

1026

6627

Flat foot [pes planus] (acquired)

137

772

1.80

9.46

1.9

1.5

0.23

0.24

g/l

0.38

131

723

Thyrotoxicosis with diffuse goitre

251

1651

1.54

9.45

1.6

1.8

0.23

g/l

0.59

233

1568

Superficial injury of wrist and hand

355

2501

1.43

9.40

1.6

1.8

0.23

g/l

0.45

336

2380

Panniculitis affecting regions of neck and back

306

2.31

9.39

1.7

1.6

0.23

0.24

g/l

0.25

286

Benign neoplasm: Small intestine

352

2.22

9.35

1.4

1.5

0.24

g/l

0.10

334

Myasthenia gravis

170

2.84

9.31

1.9

1.4

0.21

0.23

g/l

1.27

161

Nail disorders

140

800

1.78

9.27

2.1

1.6

0.23

0.24

g/l

0.34

134

759

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Complement C4 [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS